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The development of the wild type Drosophila compound eye involves stereotypical 
targeting of photoreceptor axons to the specific layers of the optic ganglion, medulla and lamina, 
in the third instar larvae. To test the hypothesis that ubiquitin ligases play an important role 
during retinal axon targeting we have examined the patterns of axon targeting in the developing 
eye of the retina aberrant in pattern (rap/fzr) mutants. Rap/Fzr is a homolog of mammalian 
Cdh1, an activator of anaphase promoting complex (APC), an E3 ubiquitin ligase. Previous work 
has shown that Rap/Fzr is required in cell cycle regulation, glia differentiation and pattern 
formation during eye development. Results from our experiments show that Rap/Fzr is required 
for proper retinal axon targeting in the developing eye. Our studies using ro-tau-lacZ show that 
the R2-R5 axons fail to stop in the lamina and mis-target to the medulla levels. Mosaic analyses 
experiments using FLP-FRT and GAL4-UAS techniques show that Rap/Fzr functions in a cell 
autonomous manner. To test for possible role of other signaling molecules and interactions with 
Rap/Fzr, we have examined rap phenotypes in double mutant combinations with Loco, Liprin-α, 
and RasV12 mutants. Our studies suggest that Rap/Fzr is required for proper axon targeting during 
Drosophila visual system development. These results are consistent with other mammalian 
studies reporting a role of Cdh1 in axon growth and targeting and provides further insights into 




Proper functioning of the nervous system requires the formation of precise neuronal 
connections. Understanding how these connections are formed is a central problem in 
neurobiology. The work presented in this thesis was conducted to test the hypothesis that 
Rap/Fzr, a Drosophila homolog of the mammalian Cdh1 is important for correct axon targeting. 
Rap/Fzr/Cdh1 is a regulatory subunit of the Ubiquitin ligase, the anaphase promoting complex 
(APC). The fruit fly Drosophila is a preferred experimental model system for study in many 
areas of biology. Drosophila offers an array of genetic tools that allow for a precise and accurate 
manipulation of genes in a tissue and stage-specific manner. The well characterized visual 
system of Drosophila comprised of the highly ordered compound eye and the optic ganglion is 
an excellent system to study the cellular and molecular mechanisms underlying the formation of 
precise neuronal connections. 
 
B1. Structure and organization of Drosophila compound eye 
 
The compound eye is made of about 750 individual units called ommatidia. ommatidium 
has eight photoreceptor cells (R cells, R1-R8), four cone cells and two primary pigment cells as 
well as shared structures such as secondary and tertiary pigment cells and sensory bristles (Ou, Pi 
et al. 2003). In each ommatidium there is a stereotypic arrangement of the photoreceptor cells (R 
cells), there are six outer R cells (R1-R6) and two inner R cells (R7 and R8). R1-R6 express 
opsin Rh1 necessary for the detection of blue light and R7 cells express UV-sensitive opsins Rh5 
or Rh4. R8 cells express either blue-sensitive Rh5 or green-sensitive Rh6 opsin (Ting and Lee 
2007). The ommatidia can be classified into subclasses based on the type of rhodopsin, they 
include, the pale subtypes that make about 30% and express the UV-sensitive Rh3 in R7 and the 
blue-sensitive Rh5 in R8, and the yellow subtype that has UV sensitiveRh4 in R7 and green-Rh6 
in R8. R7 and R8 can also detect polarized light (Morante and Desplan 2004).  
 
B2. Development of the Drosophila Eye 
 
The adult eye develops from a monolayer of epithelial tissue, the eye-antennal imaginal 
disk which is derived from a group of about 20 cells in the embryo. During the third larval instar 
stage the eye imaginal disk begins to differentiate into an adult compound eye. R cell 
differentiation starts as a wave at the posterior end of the eye disk and moves anteriorly. This 
wave is marked by a groove in the disk called morphogenetic furrow (MF). Cells posterior to the 
furrow differentiate into photoreceptor neurons while cells anterior to the furrow are unpatterned 
and undifferentiated. Two mitotic domains are seen in the developing eye disk. The first mitotic 
domain is diffuse and is seen anterior to the MF. The second mitotic domain is seen as a compact 
band immediately posterior to the MF. Cells in the MF are arrested in the G1 stage of the cell 
cycle (Ou, Pi et al. 2003). The secretion of Hedgehog (Buschhorn and Peters 2006) signal in the 
posterior part of the eye disc facilitates MF progression. Induction of Hh causes further induction 
of Hh in more anterior cells and the MF moves in a wave. It has been shown that Cubitus 
interruptus (Ci) a downstream effector of Hh can act as a transcriptional activator or repressor 
depending on its length (Ou, Pi et al. 2003). Due to the action of Hh, Ci155 accumulates at MF. 
In addition, Decapentaplegic (Dpp) allows the initiation of MF movement, and is initially 
expressed in the posterior part of the disc and later is limited just to the MF. The expression of 
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Wingless (Wg) in the posterior part of the disc, suppresses Dpp which inhibits Wg expression. 
Wg at the posterior part is suppressed by Unpaired, a ligand for the JAK/STAT signaling 
pathway. In addition, it has been shown that Hh induces Atonal (Ato), [a HLH transcription 
factor], expression in the MF and initiates neuronal development and neural induction of R8. Ato 
expression is suppressed by Hairy (H) which is turn is activated by Dpp (Greenwood and Struhl 
1999).  
 
 As the MF moves anteriorly, R cell differentiation begins posterior to it in a precise 
sequence. The R8 cell differentiates first and it recruits sequentially R2, R5 followed by R3, R4 
forming a pre-cluster of five photoreceptors. Following a second mitotic division R1 and R6 
differentiate and are recruited into the pre-cluster. The R7 cell is the last R cell to differentiate 
forming a mature cluster of eight photoreceptors. Cone and pigment cell differentiation is 
completed during the pupal stage. Thus the R8 cell plays a key role in recruiting other R cells. 
R8 secretes the ligand Spitz, which activates EGF-receptor pathway needed for recruitment of 
other R cells to the cluster, and Argos, which sequesters Spitz (Siles, Yuva-Aydemir et al. 2010). 
When R cells start to differentiate, the R cell axons of each cell forms and moves through the 
optic stalk toward the brain lobes. Each R cell has a specific target optic ganglion it stops at. 
Thus, R1-R6 terminate at the lamina but R7 and R8 terminate in the medulla (Siles, Yuva-
Aydemir et al. 2010). At the late third instar larvae stage retinal axon extend and target induction 
begins followed by the retinotopic map formation. R7 and R8 are the first to do layer-specific 
targeting in the medulla at an early pupa stage followed by R1-R6 into the lamina (Ting and Lee 
2007).  
 
B3. Photoreceptor axon targeting in the central nervous system  
 
In the wild type Drosophila the axons move from the eye disc via the optic stalk and 
terminate in the lamina or in the medulla. Axons of the R1-R6 cells will terminate in the lamina, 
while R7 and R8 axons will continue to move just beneath the R7 into the deeper layer, the 
medulla, where they terminate in two distinct layers. R8 will terminate in the M3 while R7 will 
terminate in M6 layer (see Figure 1) (Tayler and Garrity 2003). As the larva enters the pupal 
stage, additional nerve fibers enter the medulla. The R cell axons follow stereotypical axon 
projections into the optic lobe. R1-R6, neurons target to the lamina where they synapse with 
lamina neurons, L1-L5 while R7, R8 and L1-L5 form connections in single columns within the 
medulla thus, each column has the lamina neurons responsible for the motion processing and 
color vision, R1-R6, looking at a single point in space. It is currently unknown what restricts 
synaptic connections to a single column (Millard, Flanagan et al. 2007). The decision making is 
often regulated by a variety of growth factors and stop signals. For example a gene eddy will 
prevent proper eye development because the axons will not innervate the brain but will stop at 
the beginning of the optic stalk and will show clumping of the glia cells (Martin, Poeck et al. 
1995). The function of eddy is not well understood, but it was proposed that it encodes an 
extracellular molecule expressed in the brain or optic stalk that promotes outgrowth of the R 






Fig 1. This image shows photoreceptor axon projections from the eye disc to the optic lobe. R1-
R6 project to the lamina while R7 and R8 project to the medulla (Tayler and Garrity 2003). 
 
B4. Retinotopic axon projections and topographic representation of space in the Drosophila 
visual system 
 
Interestingly, in Drosophila the visual information from a single point in space converges 
onto a lamina cartridge and a medulla columns, thus each synaptic unit needs projection from 6 
different ommatidia to visualize one point in space (Clandinin and Zipursky 2002). Thus, the fly 
has a topographic representation of the visual field. Different R cells will project to different 
optic ganglion layers with R1-R6 projecting to the lamina cartridge, while R7 and R8 project to 
the medulla cartridge. The lamina neurons project in the following order: L1 to M1, L2 to M2, 
L3 to M3, L4 to M4 and L5 to M5. A cartridge is a synaptic unit within the lamina from which 
lamina monopolar neurons project to the medulla, also called a column (see Figure 2) (Clandinin 
and Zipursky 2002). The precise mechanisms of axon targeting have been widely studied but the 
exact numbers of factors involved are not known. The fly optic ganglion is subdivided into the 
lamina, medulla, and the lobula complex. The lamina is organized into columns and has about 
6000 cells and R1-6 synapse on the lamina forming functional unit. The unit is made of 5 
monopolar cells (L1-L5), one or two amacrine cells, three medulla neurons (C2, C3 and T1) and 
three glia cells. The medulla receives inputs from the inner photoreceptors and is responsible for 
the color vision. Medulla has about 40,000 cells divided by serpentive layer and axons of 
tangential neurons dividing it into a distal (outer medulla) and a proximal (inner medulla) 





Fig 2. Information from a single point in space converges onto a lamina cartridge and a medulla 
column (Clandinin and Zipursky 2002).  
 
B5. Factors affecting eye disc axon targeting to the optic lobe in the third instar larvae  
 
Important factors affecting the axon targeting are determined by the growth cones which 
change with development at they innervate appropriate target. At the beginning, R1-R6 will 
initially extend the growth cones into the lamina as a single fascicle. While in the pupal stage of 
development, growth cones tend to extend out of the cluster and innervate specific columns of 
lamina (Clandinin and Zipursky 2002). Studies have shown that R cell interaction with each 
other also plays a role in axon targeting to the lamina. Another receptor molecule needed for 
proper R8 axon pathfinding expressed in growth cones is Gogo, Golden goal. I`t is involved in 
axon-axon interaction and is needed for the proper maintenance of the distance between the R 
cells, helping R8 to reach and recognize its target in the columns of the medulla (Tomasi, 
Hakeda-Suzuki et al. 2008). Drosophila insulin receptor (DlnR) has also been shown to be 
involved in R cell axon targeting. DlnR is used as a guidance receptor for Dock/Nck that is the 
adaptor protein (Song, Wu et al. 2003).  
 
B6. Roles of retinal basal glia on the target selection  
 
Glia cells play several significant roles in the nervous system. They provide nutritional 
support for the neurons and, play role in axon guidance and signal transmission. Retinal basal 
glia (RBG) cells provide positional information for the R cell axons to enter the optic stalk and 
the brain (see Figure 3) (Tayler and Garrity 2003). The retinal basal glia are born in the optic 
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stalk then migrate into the basal surface in the eye disc where they contact R cell axons. R cell 
axons provide cues which signal the differentiation and development of the target cells in the 
optic ganglion (Clandinin and Zipursky 2002). Without RGB the axons will not project to the 
proper layers in the optic lobe. Interestingly, the glia cells do not need axons for the proper 
targeting to the eye disc but the axons need glia to extend to the optic stalk (Chotard and 
Salecker 2004). Thus, disruption of glia distribution causes R1-R6 axon mistargeting as shown in 
the nonstop mutants (Martin, Poeck et al. 1995).  
 
   
 
 
Fig 3. Glia cell locations in the optic lobe (Chotard and Salecker 2007).  
 
The molecules that guide the process of axon targeting are largely unknown but a few 
candidates have been proposed and they include Hedgehog and Dpp. Axons will stop or 
redistribute if glia cells are absent or disorganized. Mutants lacking Hh or Dpp will not project 
axons to the brain due to the stop signal and other axons will not migrate because the glial cells 
are disorganized or missing. Clumping of glia at the top of the optic stalk may lead to the 
disorganization of the axon projections as was shown in the gish mutant. gish encoded casein 
kinase I-γ, loss of gish leadsto the premature entry of the RBG to the eye disc before they have a 
chance to fully differentiate. The axons will turn away from the opticstalk (Tayler and Garrity 
2003).  
 
B7. Visual system mutations and other factors affecting axon targeting  
  
Many Drosophila mutants have been identified with defects in the targeting of the 
photoreceptor axons to the optic ganglion. Some of the phenotypes include mistargeting, hypo or 
hyperinnervation, and clumping of axons (Martin, Poeck et al. 1995; Lee, Herman et al. 2001; 
Kaminker, Canon et al. 2002; Lee, Clandinin et al. 2003). The above studies used behavioral 
screens to identify several genes involved in R cell target choice. Some of the most recently 
discovered genes required for visual system wiring are flamingo (Lee, Clandinin et al. 2003), 
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brakeless (Senti, Keleman et al. 2000), non-stop, headcase, and sequoia (Berger, Senti et al. 
2008). These genes are involved in axon growth, lamina and medulla targeting, defects in R 
cells, growth cone morphology, undershoots, R cell bypass of its target, and many other 
morphological defects that are listed in Berger’s paper. Similarly, R cell specification is still not 
fully understood. For example, Flamingo is responsible for cell-cell interactions between the 
growth cones and its levels will determine the outgrowth path (Chen and Clandinin 2008). 
Another gene identified, Sequoia is involved in the layer-specific targeting of R7 and R8 axons. 
It is a nuclear protein first expressed in R8 and then in R7. Loss of Sequoia leads to R7 cells 
mistargeting to R8 layer (Berger, Senti et al. 2008).  
 
Many mutants have specific axon projection morphology defects. For example, a 
flamingo mutant will have disorganized axons forming bundles and the medulla will be 
disturbed. Flamingo is a Cadherin-regulated cell surface protein. It allows R1-R6 cells to select 
the proper target in the lamina. flamingo also is responsible for the regulation of the dendritic 
patterning. Contrary to many other mutants, the synapses of the flamingo mutants are normal but 
made to the inappropriate targets. The study further investigated individual R cells to explain 
axon abnormalities and has shown that N-catherin and Lar contribute to the axon extensions. Lar 
and Flamingo were identified using behavioral assays for defects in the R cells but further work 
is required to investigate other potential targets and interactions of the flamingo (Lee, Clandinin 
et al. 2003).  
 
 Another aspect of the axon targeting is shown by the role of certain receptors such as 
Baboon. It will prevent R7 axons terminals to go to the right target. Baboon is the Activin 
receptor that prevents R7 cells overlap with other columns of R7 cells. It was suggested that 
dActivin is a molecule that will restrict R7 growth cone movement. Activin action will lead to 
axon repulsion from the neighboring columns of the R7 cells. The importance of this molecule is 
that it provides an example of a molecule that restricts axons to the same column but if expressed 
in the improper layer in the optic lobe and will lead to improper axon targeting. The molecular 
signaling pathway is not well understood. Thus, a loss of Activin or mutations in Babo will lead 
to improper column infestation of the axons (Ting and Lee 2007). Also, expression of a gene in 
the wrong cell may force a specific cone to differentiate into another cone. For example, Runt a 
transcription factor from the Runt domain famil, is expressed in two inner R cells (R7 and R8). 
Upon misexpression of Runt in the R2 and R5 the axons will be misguided from their normal 
path (Kaminker, Canon et al. 2002). Axons in Drosophila have highly specific targets have the 
ability to retreat or bypass their target. For example, a Lar mutant will go to its target but will 
retreat to the wrong position, while the brackeless will not care about the stop signals but will go 
through the tissue to the last layer in the brain, as the name suggests without brakes, terminating 
in the medulla. Brakeless is responsible for the proper targeting of the R1-R6 and is present in 
the nuclei of all R-cell types (Tayler and Garrity 2003).  
   
B8. The ubiquitin-proteosome pathway  
 
Protein degradation is an important element of normal cellular maintenance. It plays a 
role in the elimination of damaged, mislocalized or foreign proteins. One of the well studied 
pathways involved in protein degradation is the ubiquitin-proteosome pathway. Ubiquitin is a 
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small, 76 amino acid protein which is attached to the target proteins. The ubiquitin has an 
attachment sites on the C-terminus where ubiquitin is added to ε-amino group of a lysine residue. 
The enzymes involved in the attachment are E1, E2, and E3 (Murata, Yashiroda et al. 2009). E1 
is the ubiquitin-activating enzyme found in the nucleus and the cytoplasm. E2 is an ubiquitin-
conjugating enzyme while E3 is ubiquitin-protein ligase responsible for the recognition of the 
protein substrates. E1 will transfer activated ubiquitin to E2 forming a thioester bond and then 
ubiquitin if transferred from E2 via E3 to the target site (McNaught, Olanow et al. 2001). RING -
E3 binds to E2 and a substrate to help E2 with the transfer of ubiquitin to a substrate while 
HECT-E3 uses thioster bond with the ubiquitin before it is transferred to the substrate (see 
Figure 4) (Murata, Yashiroda et al. 2009). The E3 Ubiquitin ligase contains RING finger domain 
in which Cysteine and Histidine residues are ligands to two Zinc ions. RING E3 allows for the 
direct transfer of ubiquitin from E2-Ubiquitin to substrate (Deshaies and Joazeiro 2009). In 
general the monoubiquitination of proteins has regulatory effects while polyubiquitionation of 4 
or more residues targets proteins for degradation by 26S proteosome (Deshaies and Joazeiro 
2009). Monoubiquitination of different lysine residues can have diverse effects on the proteins 
due to the posttranslational effects on the protein function, structure, assembly and localization 
(Deshaies and Joazeiro 2009).  




Fig 4. An E3 ubiquitin-proteosome pathway (Ou, Pi et al. 2003). 
The 26S proteosome is responsible for degradation of cyoplasmic, nuclear and membrane 
proteins where ubiquitin is recycled but not degraded. Eukaryotic proteosome are large protein 
complexes of about 2000 kDa consisting of 20S particles, core and a lid. The core particle is 
made of 7-membered rings and two types of subunits, alpha and beta, where only beta subunits 
are catalytically active. The lid plays a role in regulation of the activity and is involved in the 
energy dependent steps (Adams 2004). The 20S particle is made of about 14 different subunits 
and relies of 5 different cofactors for its assembly. The base has six ATPase subunits (Rpt1-6) 
that form hexameric ring with Rpn1 and Rpn2 and relies on chaperones for proper folding, p27, 
P28, S5b and Rpn14 in mammals (Besche, Peth et al. 2009) but the exact assembly sequence is 
not well known. Also, ubiquitin-proteosome system was shown to affect axon pruning needed 
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for a refinement of the neuronal connections in animals; thus, protein degradation plays a crucial 
role in axon pruning and Wallerian degeneration which can be inhibited by UPS (Korhonen and 
Lindholm 2004). APC is a E3 ubiquitin ligase responsible for conjugation of Lys-48-linked 
polyubiquitin chains to the substrate proteins and subsequent targeting them to the 26S 
proteosome (Passmore 2004).  
.  
B9. Anaphase Promoting Complex/Cyclosome  
  
APC/C (APC) was first described in Xenopus laevis in 1995 as a multi-subunit protein 
with ubiquitin ligase activity needed for cell-cycle transitions (see Figure 5). It was named after 
its main role, being necessary during the anaphase in yeast and mammalian cells (King, Peters et 
al. 1995). The complete picture of the functions of APC is currently unknown but multiple 
pathways were shown to be involved. The discovery that APC is expressed in the brain tissue 
allowed the exploration of additional roles for the APC. It was shown that Cdh1, a regulatory 
subunit, has a high expression levels in the postmitotic neurons especially in the cerebellum, 
cerebral cortex and hippocampus while Cdc20, another APC activator, is practically absent in 
these regions (Gieffers, Peters et al. 1999). Cdh1 binds substrates through its interaction with the 
D box (destruction box), which is made of nine amino acids, RxxLxxIxN, found on its substrates 
such as cyclin B. Mutations in the D-box prevent protein degradation (Bashir, Dorrello et al. 
2004). Cdh1 also recruits substrates that have KEN box (KENxxxN), A-box, and CRY box 
(Kaplow et al., 2007(Kim and Bonni 2007). APC has a V shape with APC11 and APC 2 on the 
outside and Cdh1 on the inside thus it was suggested that the APC E3 ligase activity is on the 
inside while ubiquitination on the outside of the complex (Kim and Bonni 2007). APC-Cdh1 is 
regulated by phosphorylation and dephosphorylation of Cdh1. Phosphorylation inhibits APC-
Cdh1 binding as well as its interactions with other inhibiting proteins such as Emi1 and Mad2b 
(Kim and Bonni 2007). Cdc20 and Cdh1 contain WD-40 repeats in the C-terminus forming a 
seven-bladed propeller structure needed for the protein-protein interactions that recruit substrates 
for ubiquitination. Cdc20 plays a role in the activation of APC in mitosis but to remain active in 







Fig 5. Composition of Anaphase Promoting Complex/Cyclosome (Peters 2006). 
 
B10. rap, (retina aberrant in pattern), a Drosophila homolog of mammalian Cdh1 
 
rap (retina aberrant in pattern) encodes the Fizzy-related protein (Fzr) which is an 
activator of Anaphase Promoting Complex, APC, an ubiquitin ligase complex. Rap/Fzr is a 
homolog of a mammalian Cdh1. Previous studies have shown that Rap/Fzr plays significant roles 
in eye development (Karpilow, Pimentel et al. 1996). Additionally, recent data have shown that 
rap regulates the glia differentiation in the developing CNS through interactions with Loco. 
Partial loss-of function mutations cause an increase in number of surface glia in the third instar 
larvae, while a gain-of-function mutations lead to an increase in neurons (Kaplow, Korayem et 
al. 2008). Overexpression of Rap/Fzr has shown progressive neurodegeneration, temperature-
sensitive paralysis and life span reduction (Mino, et al., unpublished data). In addition, 
unpublished data suggest possible roles of rap/fzr in synaptic plasticity and bouton morphology 
and structure (A. Wise, unpublished data). A genetic modifier screen has identified 39 other 
genes which interact with Rap/Fzr and are involved in ubiquitin mediated proteolysis, signal 
transducers, transcription regulation (Kaplow, Mannava et al. 2007).  
 .  
B11. Neuronal roles of mammalian Cdh1 
  
 In the mammalian nervous system Cdh1 expression is localized to the brain neurons in 
the cortex, hippocampus, and cerebellum while Cdc20 is very limited in the brain (Kim and 
Bonni 2007). It was shown that APCCdh1 may play a role in the axonal growth and control of 
patterning. Depletion of Cdh1 by RNAi in neurons of the rat cerebellar cortex caused axonal 
elongation, but not the dendritic growth. The phenotype can be rescued by RNAi-resistant Cdh1 
(Konishi, et al., 2004). It was also suggested that expressing APC11 or Emi1 that normally 
inhibits APC, also increased axonal length (Konishi, Stegmuller et al. 2004). Surprisingly, with 
Cdh1 knock down neurons can grow in the presence of inhibitory myelin thus suggests potential 
therapeutic regenerative possibilities of neurons (Konishi, Stegmuller et al. 2004).  
 
B12. The role APC/Cdh1 in regulation of axonal length in mammals  
 
Several laboratories began to seek ubiquitinated substrates that play a role in the axonal 
outgrowth. One is SnoN, a transcriptional co-repressor, expressed in post-mitotic neurons. RNAi 
knockdown of SnoN decreased the length of axons, suggesting that SnoN promotes axonal 
elongation. Interestingly, SnoN-RNAi inhibits axonal growth in RNAi-Cdh1 cultures 
(Stegmuller, Konishi et al. 2006). SnoN physically interacts with Cdh1, which causes SnoN 
ubiquitination and proteosomal degradation in primary cerebellar granule neurons. Thus, RNAi-
SnoN prevents axonal outgrowth (Stegmuller, Konishi et al. 2006). SnoN interacts with p300, a 
transcriptional co-activator, to promote axon growth; thus, SnoN plays two roles, and it can 
activate or repress transcription in a cell-specific or gene-specific manner (Ikeuchi, Stegmuller et 
al. 2009). The roles of transcriptional mechanisms used in axonal elongation and stabilization are 
not fully understood. Ubiquitination starts to emerge as a powerful “cell-intrinsic regulator” in 
the determination of the axonal lengths. For example, it was shown that ubiquitinated proteins 
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play a crucial role in the regulation of axonal growth (Stegmuller, Konishi et al. 2006). 
Identification of substrates needed for APC-Cdh1 is necessary to determine what controls the 
axonal development. Additional proteins involved in inhibition of axonal growth are Sema3F, 
Jagged-2, Unc5A, Notch1 and Nogo receptor. The mechanism involved was suggested to 
involve Cdh1 knockdown that is able to stabilize Id2 and inhibit E protein-mediated Nogo 
receptor transcription, since Id2 is a substrate for APC-Chd1 (Kim and Bonni 2007). Another 
Cdh1-APC substrate that plays a role in the axon growth is Id2, inhibitor of DNA binding 2, that 
is recognized by the D-box and is ubiquitinated and degraded; thus, it promotes axon growth 
since mutated D-box promotes it; similarly, Id2 with mutated D-box overcomes the inhibitory 
functions of myelin and axons grow (Yang, Kim et al. 2010).  
 
Axon guidance and growth utilizes cues via the cell surface receptors which use the 
cytoskeleton to attract or repulse the axon growth cone (Dent and Gertler 2003). Cdh1 and 
Cdc20 are modified post-translationally by ubiquitination, phosphorylation, and interaction with 
APC inhibitor (Yang, Kim et al. 2010). Cdh1 regulates axon morphogenesis while Cdc20 is 
involved in dendrite morphogenesis, and Cdh1-APC operates mainly in the nucleus (Yang, Kim 
et al. 2010). Cdh1 may be phosphorylated at 11 sites in yeasts and 9 residues in mammals; 
phosphorylation on Ser40, 151, and 163, Thr121 promotes the nuclear export of mammalian 
Cdh1 (Huynh, Stegmuller et al. 2009). Phosphorylation of Cdh1 at Cdk sites disrupts the 
association of Cdh1 with the APC core protein Cdc27 and promotes cytoplasmic accumulation 
of Cdh1 in granule neurons (Huynh, Stegmuller et al. 2009). Cdh1 is able to autoubiquitinate 
itself; thus, phosphorylation of Cdh1 at Cdk sites may prevent autoubiquitination of Cdh1 
(Huynh, Stegmuller et al. 2009).  
 
B13. Liprin-α  
  
When we look at the molecular level of the axon targeting there are many unknowns. In 
the literature we can find specific molecules that act as the stop and go signals. We find an array 
of proteins that seem not to be connected with each other, but at the end influence the phenotype 
in dramatic ways. These proteins are often multifunctional and their concentration and locations 
affect the axon targeting as well. Thus, expression of the protein in the wrong place can cause 
axon mistargeting or can cause all axons to go to only one target resulting in numerous 
projections. One interesting molecule is Liprin-α, which is a scaffolding protein required for 
proper axon targeting. Liprin-α is localized at the synapse, and is a substrate for APC/Cdh1. 
Mutations in the Liprin-α will affect axon target selection in R1-R6 photoreceptors (Choe, 
Prakash et al. 2006). Liprin-α is a protein with N-terminal coiled-coil domain and C-terminal 
LAR-binding liprin homology domain, which is made of three sterile alpha motif (SAM) 
domains (Hofmeyer, Maurel-Zaffran et al. 2006). Liprin-α plays a role in the NMJ, anterograde 
transport and accumulation of synaptic vesicles presynaptically (Prakash, McLendon et al. 2009). 
Liprin-α is also involved in the regulation of synaptic function and is targeted by APCCdh1 acting 
as a substrate at the neuromuscular junction (van Roessel, Elliott et al. 2004). Liprin-α mutants 
show defective axon guidance and are required presynaptically to mediate adhesive events 
between pre- and postsynaptic cells (Choe, Prakash et al. 2006). Hofmeyer showed that Liprin-α 
overexpression can partially restore R7 targeting and its removal may worsen the targeting when 
LAR is absent (2006).  
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B14. Loco and its known roles   
 
The regulators of G-protein signaling (RGS) are an important family of proteins critical 
in the regulation of signaling mediated by G-coupled receptors [GPCR] (Yu, Wang et al. 2005). 
GPCR s are found at the cell surface and are linked to the G protein to initiate a signaling 
cascade. G proteins are made of Gα subunit and Gβγ heterodimer (Granderath and Klambt 
2004). Gα is inactive when it is bound to the GDP and is a part of the Gβγ complex. Once 
activated, it replaces GDP with GTP. Then, Gα subunit separates from the complex and is able to 
activate downstream targets. Gα has an intrinsic GTPase activity to hydrolyze GTP (Granderath 
and Klambt 2004). RGS proteins activate the GTPase activity of Gα subunits and allows for a 
faster transfer of GTP-bound active to GDP-bound inactive form. 
 
 In Drosophila, nine genes, such as axin (a scaffold protein), gprk 2(G-protein-coupled 
receptor kinase2) and loco (McGurk, Pathirana et al. 2008), are known to encode RGS proteins 
in Drosophila. locomotion defects (loco) encodes a member of an RGS protein family and is 
involved in the G-protein signaling. It was identified using P-element enhancer trap insertions 
and the loco gene encodes four possible transcripts by alternative splicing, LocoP1-P4 encodes 
different Loco isoforms of the following amino acid length: 829, 1175, 872, and 1541 
(Granderath and Klambt 2004). Loco has RGS domain and Go Loco motif that plays a role as a 
Guanine nucleotide dissociation inhibitor (GEF). In addition, loco is expressed primarily in the 
neuroblasts and in the lateral and midline glia cells in the central nervous system. Loco is 
required for the correct development of the blood brain barrier and the ensheathment of the 
neuronal bodies and axons. It was shown to physically interact with the Gαi using yeast-two 
hybrid screen while having the highest homology to mammalian RGS12 and RGS14 
(Granderath, Stollewerk et al. 1999; Ponting 1999). Loco P1 is expressed in the central nervous 
system, primarily in the lateral glia cells throughout the development and in adult (Granderath 
and Klambt 2004).  
 
 Very little is known about loco expressions in non-glia cells but it was shown to be 
involved in the dorso-ventral patterning and circadian regulation of gene expression (Claridge-
Chang, Wijnen et al. 2001; Pathirana, Zhao et al. 2001). Different alleles of loco reduce the 
lifespan and impair locomotion, thus giving loco its name (Granderath, Stollewerk et al. 1999). 
Loco was also found to play a role in male reproductive system differentiation (McGurk, 
Pathirana et al. 2008). The primary roles of Loco are the formation, extension and migration of 
glia cells and the asymmetric division of neuroblasts (Yu, Wang et al. 2005). It was shown that 
the loco gene is required for glial differentiation and triggers glial migration or differentiation in 
the brain but the exact mechanisms are not known (Siles, Yuva-Aydemir et al. 2010).  
 
B15. Ras and the APC complex  
 
A possible interaction between of Ras and APC/Cdh1 was suggested through studies on 
Ets2. Ets2 is a transcription factor that is activated by Ras-Raf-MAPK signaling and induces 
cyclin D1. Increased expression of Ets2 has been implicated in several cancers. APC-Cdh1 
regulates the process since it targets Ets2 for degradation and thus limits the expression of cyclin 
D1 (Li and Zhang 2009). This suggested a possible interaction of Ras and APC-Cdh1and its role 
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as a tumor suppressor. Interestingly, the Ras interaction with APC-Cdh1 is not well 
characterized. It was also suggested that the APC-Cdh1 may have an inherent tumor suppressor 
activity, due to its roles in cell cycle regulation and thus may play a role in the genomic stability 
and generation of cancer. It was also shown in various cancers that the several mutated APC 
components were tumorgenic (Turnell and Mymryk 2006) but the exact role of APC in the 
process is unknown. Thus, the suggestion that overexpression of APC substrates may lead to 
genomic instability and tumorgenesis (Turnell and Mymryk 2006) needs to be further 
investigated. Turnell et al. (2006) cites several cases of cancers caused by the APC/C substrate 
problems. RasV12 mutation was shown to cooperate to cause tumor growth and invasion when 
combined with loss-of-function scribbled which is a tumor suppressor gene with the involvement 
of JAK/STAT signaling pathway. It was shown that RasV12 causes cell overgrowth in the eye 
imaginal disc of Drosophila and is an oncogenic form of Drosophila Ras85D (Wu, Pastor-Pareja 
et al. 2010). The Valine mutation makes the Ras constitutively active.  
 
C. RESULTS  
C1. rap mutants exhibit axonal targeting abnormalities.  
The partial loss-of-function mutations in the Drosophila rap gene cause a rough external 
phenotype when compared to the wild type Canton. It was previously shown that these mutations 
cause additional aberrant mitotic cell cycles in the developing eye (Pimentel and Venkatesh 
2005). Examination of the protein expression patterns of Rap/Fzr showed that it is expressed in 
the nucleus of the post mitotic photoreceptor neurons; thus, it lead us to investigate whether 
Rap/Fzr has a neuronal function (Pimentel and Venkatesh, 2005). The partial loss-of-function 
alleles in the rap mutants cause a range of severity in the external rough eye phenotype as 
compared to the laboratory wild type, Canton S flies. Thus, to test whether Rap/Fzr in the 
developing R cell neurons plays role in axon targeting, we used Drosophila eye as an 
experimental model to examine axon projection patterns in developing eyes from rap loss-
of-function mutants. The R cells have stereotypical axonal projections, R1-R6 innervate the 
lamina while R7 and R8 innervate the medulla in a stereotypical manner. To address the question 
of axonal targeting we utilized the development of Drosophila eye which develops from the eye 
imaginal disc that is attached through the optic stalk to the optic lobes in the third instar larvae.  
 
We used six different rap alleles previously generated by various methods of mutagenesis 
such as X-rays (rapx-2 and rapx-3), EMS (rapE2, rapE4, and rapE6), and P-element (w,rap3) by 
Tadmiri Venkatesh laboratory. These alleles were analyzed using immunohistochemistry and 
visualized using confocal microscopic imaging for the abnormalities in the axonal projection 
patterns. The photoreceptor axons were stained with Mab 24B10, which was previously 
identified to stain photoreceptor cells and their axons in the eye imaginal disc (Zipursky, 
Venkatesh et al. 1985). The wild type third instar eye discs of CS and w1118 (white mutation, no 
pigment expression, previously shown to have normal photoreceptor axon projection patterns) 
flies show stereotypical axon projections from the eye imaginal disc, through the optic stalk, with 
well organized lamina and medulla axons and a well defined lamina plexus (Fig 6. A, B). Rap 
mutant alleles showed aberrant retinal axon projections. The different rap mutants examined 
show allele specific variation in phenotype, with rapx-3, rapE4, and rapE2, (Fig. 6. D, E, F) 
showing photoreceptor axon overgrowth. All mutants show gaps in the lamina plexus, axonal 
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clumping, disorganized lamina and medulla layers (Fig. 6. C-H). The rap alleles show specific 
variations in the abnormal phenotype suggesting that Rap operates in a gene dosage dependent 
manner.  
 
































Fig 6. The wild type (CS and w1118) Drosophila eye shows proper innervations in the lamina and 
medulla. Each is a stack image composed of 20-30 focal planes, each advancing 1.5 µm along 
the z-axis. The axon projections do not show clumping or disorganization. They follow 
stereotypical patterns of targeting. rap mutants show allele specific abnormalities, lamina gaps 
(shown with arrows), disrupted medulla and axonal overgrowth. Shown axon projection patterns, 
stained with 24B10. Arrows point to the gaps in lamina plexus, arrowheads show sample 
overgrowth areas of axons.  
 
Since, we saw abnormal axonal projection patterns in the photoreceptor axons of rap 
alleles; we performed a detailed analysis of the six rap alleles by measuring their axonal lengths. 
The measurements included: a) the lengths of R1-R6 from the base of the optic stalk to the 
lamina plexus, b) R7-R8 from the base of the lamina plexus to the end of R7-R8 growth cones, c) 
the width of the lamina plexus, and d) the width of the optic stalk at the base of the eye disc. The 
lengths were quantified using projected images obtained from z-stack images generated using 
LSM Image Browser.  
 
A statistical analysis of the results shows significant changes in the lengths of the lamina 
plexus and R cell axon length. The average lengths of the measured axonal projections, their 
significance and standard error are plotted in the Figure 7. The percent increase of the 
statistically significant alleles was the following: rapE2 showed significant differences in the 
length of the R1-R6 cells (33.18%, P value=0.0032, St. Dev.=5.259, n=8) and the lamina plexus 
(40.84%, P value=0.0054, St. Dev.=21.47, n=8). rapE4 allele showed significant differences in 
the R7-R8 cells (49.63%, P value=0.0038, St. Dev.=24.76, n=7) and the lamina plexus (19.61%, 
P value=0.0010, St. Dev.=24.76). rapE6 allele showed significant differences in R1-R6 cells 
(24.65%, P value=<0.0001, St. Dev.=4.934, n=7). rapx-3 showed significant differences in R1-R6 
cells (5.58%, P value=<0.0001, St. Dev.=9.869, n=11). w,rap3 showed significant differences in 
R7-R8 cells (37.87%, P value=0.0385, St. Dev.=55.78, n=15) (see Table A1-3 in Appendix). 
Additional parameters are needed to assess the severity of axonal projection patterns. Those 
include quantification of the number of axons, in mutants that the number cannot be easily 
distinguished; measuring number of clumps per square centimeter may be a good way to assess 
for the more severe phenotypes since the clumps make it difficult to accurately measure the 
number of axons present.  
 
Our results are consistent with function of Rap/Fzr as an inhibitor of axon growth and 
elongation. Similar results were shown in the mammalian homolog Cdh1, where knock down of 
Cdh1 using siRNA in the axons in the cerebellar cortex showed growth and elongation (Konishi, 
Stegmuller et al. 2004). The alleles, rapx-2, rapx-3, and w, rap3 (Fig 6. C, D, and H) showed 
additional gaps in the lamina plexus, axon bundling in the medulla and lamina as well as the 
increase in the overall length of the projections (Fig 6. F-H). The results indicate that Rap/Fzr 
plays a role in the determination of axonal growth and inhibits axonal growth; thus, partial loss 
of function clones show an increased length of the photoreceptor axons (Figure 7, Table 1 in the 
Appendix). The data is supported by the mammalian studies using Cdh1 mammalian homolog of 
rap, that show that axonal growth in the central nervous system is affected by the loss-of-





Figure 7. Histogram representing rap allele R cell photoreceptor axon measurements. The 
percent increase of the statistically significant alleles was the following: rapE2 showed significant 
differences in the length of the R1-R6 cells (33.18%, P value=0.0032, St. Dev.=5.259, n=8) and 
the lamina plexus (40.84%, P value=0.0054, St. Dev.=21.47, n=8). rapE4 allele showed 
significant differences in the R7-R8 cells (49.63%, P value=0.0038, St. Dev.=24.76, n=7) and the 
lamina plexus (19.61%, P value=0.0010, St. Dev.=24.76). rapE6 allele showed significant 
differences in R1-R6 cells (24.65%, P value=<0.0001, St. Dev.=4.934, n=7). rapx-3 showed 
significant differences in R1-R6 cells (5.58%, P value=<0.0001, St. Dev.=9.869, n=11). w,rap3 
showed significant differences in R7-R8 cells (37.87%, P value=0.0385, St. Dev.=55.78, n=15). 
 
C2. Photoreceptor cell axons R2-R5 show mistargeting in rap mutants.  
 
The 24B10 antibody used to visualize rap mutants and labels all R cells. Thus, it does not 
distinguish among the inner (R1-R6) and outer (R7 and R8) photoreceptor axons. In order to 
determine which photoreceptor axon group causes the abnormal phenotype, a ro-tau-LacZ 
reporter was utilized. The reporter ro-tau-LacZ permits the selective labeling of the R cell axons 
R2-R5 (Fan, Soller et al. 2005). The ro-tau-LacZ marker was crossed into the rap mutant 
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background and the axon projections examined. The wild type, CS, and the ro-tau-LacZ 
(parental strain) show well defined lamina axons stained with anti-beta-galactosidase antibody 
(Fig 8. A-B). rap alleles show R2-R6 photoreceptor axons crossing the lamina plexus and 
terminating in the medulla. Also, in many instances R cells tend to clump at the lamina plexus, 
causing gaps (Fig 8. D-I). It was also noticed that ro-tau-LacZ reported was leaky. It was 
previously utilized using horseradish peroxidase staining, which is not as specific as antibody 
staining; thus, some of the expression was also seen in the R7-R8 cells, but the expression was at 
a lower level in the parental strain than in the double mutant cells. The data suggests that in rap 
partial loss-of-function alleles of rap cause developmental axonal changes, possibly changing the 
photoreceptor outgrowth or affecting proper R cell axon targeting.  
 
 
Fig 8. R2-R5 axons were visualized selectively with a ro-tau-lacZ reporter to assess targeting to 
the lamina in third instar optic lobe. A) ro-tau-lacZ parental strain; B) ro-tau-lacZ/Y male 
parental stock which shows some leakiness to the R7-R8 cells. The double mutant crosses rap 
and ro-tau-LazZ: C) LocoP452/+; ro-tau-lacZ/+; D) rapE2/Y; ro-tau-lacZ; E) rapE4/Y; ro-tau-lacZ; 
F) rapE6/Y; ro-tau-lacZ; G) rapx-2/Y; ro-tau-lacZ; H) rapx-3/Y; ro-tau-lacZ; I) w, rap33/Y; ro-tau-
lacZ. Arrows point the R2-R5 cells bypassing the lamina plexus.  
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C3. Rap/Fzr functions cell autonomously in retinal axon targeting 
 
Mosaic analysis is a useful tool in studying lethal mutations, allowing certain defects to 
be expressed only in particular places, tissues or cells; thus, permitting for an in vivo comparison 
of the wild type and mutant phenotypes. Mutant clone phenotypes are a common way to assess 
for cell-autonomous functions. Mosaic analysis methods are widely used to study mutations in a 
tissue-specific or time-specific manner to see additional developmental influences of the mutants 
to the wild type background. Eye-antenna disc was one of the first tissues used for the generation 
of clones in a living organism (Xu and Rubin 1993). As previously shown by other groups, many 
other mosaics also showed defects in the axonal projections and when compared to the wild type 
phenotypes it was seen that the axons projected to the wrong target taking unusual routes, 
misguided by the wrong signals. For examples, in the Flamingo mutant, mosaics showed that 
mutations in Flamingo would lead to the mistargeting of the axons in the medulla (Takeichi 
2007). The axons were seeking the wrong target but often times the synapses formed were 
normal. In this case, homozygous flamingo mutant was lethal and could not be studied by 
conventional ways.  
 
 Similarly, rap expression is necessary for the survival of Drosophila since rap null alleles 
are lethal; thus, rap is an essential gene for the development of the fruit fly. The assessment of 
whether the rap mutation is cell autonomous or non-cell autonomous, in an organism that cannot 
survive the complete loss-of-function, the generation of clones is necessary. To assess whether 
Rap/Fzr function in axon targeting is cell autonomous, genetic mosaic analysis was performed by 
generating mitotic clones in the developing visual system. Mosaic studies were used to test cell-
autonomous functions of the rap gene regulating axon projections to their targets. The 
advantages of using mosaic studies is that patches of tissue of the animal will express normal 
patterns while other parts will express the mutant phenotype; in other words, we will obtain 
homozygous null rap-/rap- mutant clones in the overall homozygous wild type, rap+/rap+ twin 
spot, background.  
 
A system widely used to generate mosaic clones is FLP-FRT system in Drosophila which 
allows for an efficient mitotic clone generation using the heat shock promoter driving Flippase 
expression combined with FRT. This site-specific recombination system allows for a deletion of 
a particular gene of interest. FLP is a site-specific recombinase which recognizes FRT (FLP 
recombination target) sites (Theodosiou and Xu 1998). Heat shock and eye Flp promoters were 
used to express the Flippase enzyme. GFP fusion reporter was used to localize and visualize the 
clones. FLP will cause recombination by excising the DNA fragment between the FRT sites and 
remove the rap allele.  
 
Our preliminary data show that the regions of the rap-/rap-clones identified by the 
absence of GFP staining show aberrant axon projections. The eye disc morphology of rap-/rap- 
clones is shown in Fig 9. Clumping of axons and various gaps in the lamina plexus were 
observed in the clone patches but the general morphology of the surrounding cells is normal. The 
phenotype appears cell autonomous since the surrounding genotypically heterozygous or wild 
type tissue is phenotypically normal. The clones were generated using two different reporter 
lines with Hsp FLP on different chromosomes to test the signal strength (Fig 10. A-D, I-L). The 
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clones are enclosed with a white line (Fig 10. E-I, M-P). The visualization of clones in the third 
instar larva poses a challenge, only the clones in the optic lobe surface can be seen; thus, the 
images do not show clones on the interior of the lobe. This explains why axons in other brain 
regions besides the enclosed clone areas shown on the Fig 10. have abnormal axonal patterns, 
forming clumps, gaps and disorganized lamina plexus. These data suggest that Rap/Fzr function 
is cell autonomous. Additional experiments need to be performed for more definitive conclusions 
such as MARCM, mosaic analysis with a repressible marker, that allows visualization of a single 




Fig 9. Loss of function clones of rap-/rap- using FRT site specific recombination. Genotype: 
w67c23 P{lacW}rapG0418 P{neoFRT}19A/FRT19,UbiGFP,eyFLP; P{ey-FLP.D}5/+. The 
arrows point to the areas where rap-/rap- clones were generated in the eye disc, showing 






Figure 10. The loss-of-function rap clones. A-D and I-L. Show parental strains used to generate 
the clones. The image shows axonal clumping, mistargeting of photoreceptor axons, 
disorganized lamina plexus and the overall morphology of the clones is affected. Images D, H, L, 
and P are merges of GFP, 24B10, and anti-betagalactosidase staining. The genotype are: A-D: 
FRT19,UbiGFP,eyFLP1/Y;+/+; +/+; and I-L: FRT19,UbiGFP/Y; +/+; hs.FLP/+; E-H. and M-P. 
Show the loss-of-function clones outlined in white. Genotypes: E-H: w67c23 P{lacW}rapG0418 
P{neoFRT}19A/FRT19,UbiGFP,hs.FLP1; P{ey-FLP.D}5/+; +/+; and M-P: w67c23 
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P{lacW}rapG0418 P{neoFRT}19A/FRT19,UbiGFP; P{ey-FLP.D}5/ +; hs.FLP/+. Staining: 
GFP=GREEN; 24B10=RED; ANTI-BETAGALACTOSIDASE=BLUE 
C4. Gain-of Function experiments show that Rap/Fzr is required for proper axon 
targeting. 
 
The data suggested that loss-of-function caused an increase in the R cell length, we 
wanted to examine whether the gain-of-function will cause the opposite, axonal shortening. To 
test the effects of over expression of Rap/Fzr, gain-of-function rap/fzr clones were generated and 
screened for photoreceptor axon projection using two systems: UAS/GAL4 and FLP/FRT.  
Thus, we asked whether the gain-of-function in Rap/Fzr modulates proper axon targeting 
and length.  
 
The gain-of-function experiments are a useful way to study the effects of the 
overexpression of a given protein. This experiment utilizes UAS/GAL4 system (Duffy 2002) 
combined with FLP/FRT system (Golic, Rong et al. 1997). The gain-of-function study ensures 
that the protein in question is causing the alteration of the phenotype. UAS/GAL4 system allows 
direct assessment of the effect of expression of a gene of interest with the ability to report and 
visualize its activity. GAL4 is a transcriptional activator from yeasts, and is expressed in tissue 
specific manner while UAS is a transgene, an upstream activator sequence (St Johnston 2002). 
The rap gene was cloned downstream of a UAS sequence and the gene expressed in the presence 
of GAL4 protein that binds to the UAS and activates transcription. Both GAL4 and UAS-rap/fzr 
are carried in different strains, allowing the parental viability. It also allows for the GAL4 to be 
expressed in a spatial pattern; thus, depending on the tissue promoter used the gene under UAS 
can be overexpressed in a variety of tissues if crossed to the GAL4 line (McGuire, Roman et al. 
2004). 
 
 The experiment utilizes the UAS-fzrII.I, UAS-GFP as a visible reporter gene, and 
combines the UAS/GAL4 system with heat shock FLP and Actin>CD2>FRT-GAL4 UAS-GFP 
cassette, (where > are FRT sequences). Under a heat shock, Flippase will be activated causing 
site-specific recombination of the FRT sequences and excision of the FRT>CD2 flanking 
sequence. The excision will allow the expression of GAL4 from the Actin promoter and binding 
of the GAL4 protein to the UAS sequences and activating the expression of rap/fzr and GFP 
reporter gene. All cells labeled with GFP will also overexpress Rap/Fzr protein allowing for the 
visualization of the affected cells.  
 
 The heat shock was administered 24 (Fig 11. A-D, Fig 12. A-D) or 48 hours (Fig 11. E-P, 
Fig 12. F-T) after egg laying at 37°C water bath. The gain of function clones show axon 
clumping in early induced clones (Fig 11). It was previously shown that gain-of-function of rap 
causes an increase in the neuroblast and decrease in the glia numbers in the optic lobe of 
Drosophila (Kaplow, Korayem et al. 2008). Thus, the gain-of-function of rap/fzr in the eye 
imaginal disc causes axonal clumping, disorganization of lamina plexus with many gaps. These 
data suggest that Rap/Fzr is necessary for proper axonal targeting and proper development 
of the Drosophila visual system that begins in the third instar larvae. Interestingly, the 
lamina plexus shows clusters of R cells fluctuating from the proper orientation in a step-wise 
Marta Gronska Thesis | 23  
 
fashion. It suggests that the overexpression of Rap causes an increased number of neurons that 
cannot fit onto the plane of the lamina plexus and cause the disorganization of that region. 
Although, the photoreceptor axons were not measured the length of the R cells is significantly 
decreased. Further measurements are necessary to assess the significance of the decrease.  
 
 
     
Fig 11. Gain-of-function rap clones expressing GFP and FZR. The gain of function clones show 
axon clumping (shown with arrow), axonal bundles and shortening of axons in early induced 
clones. A-D heat shocked after 24 hours, E-P heat shocked after 48 hours. D is a merge of A-C; 
H is a merge of E-G; L is a merge of I-K; and P is a merge of L-O. Genotype: hsp.FLP/+; UAS-




Fig 12. Additional data showing gain-of-function rap clones expressing GFP and FZR. The gain 
of function clones show axon clumping (shown with arrow), axonal bundles and shortening of 
axons in early induced clones. A-D heat shocked 24 hours after egg laying, F-T heat shocked 24 
hours after egg laying at 37°C water bath for 15 minutes. E is a merge of A-D; J is a merge of F-
I; O is a merge of K-N; and O is a merge of P-S. Genotype: hsp.FLP/+; UAS-fzr II.I/+; 
Act>Gal4 UAS-GFP/+. Staining: 24B10=RED, GFP=GREEN; REPO=BLUE; DAPI=WHITE.  
C5. Loco dominantly interacts with rap to regulate axon targeting 
 
Previous studies have shown that Rap, an ubiquitin ligase, targets Loco for ubiquitination 
and degradation (Kaplow, Korayem et al. 2008), thus we decided to investigate possible 
interactions of Rap and Loco in axonal targeting asking whether Loco dominantly interact with 
rap to regulate axon targeting. Loco was previously shown to affect the number of neurons and 
glia (Kaplow, Korayem et al. 2008); thus, it may play a role in axonal targeting.  
 
To test for dominant interactions between Rap and Loco we constructed rap loss-of 
function mutants with a single copy of the loco loss-of-function mutation. The double mutants 
were screened for the axonal projection patterns. The locoP452 allele is a homozygous lethal with 
rare third instar escapers that are characterized by locomotion problems and pupal lethality (Yu, 
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Wang et al. 2005). Third instar larvae escapers were stained for photoreceptor axons (Fig 13. B) 
and showed a diffuse lamina plexus with generally wild type axonal projections to the medulla. 
The cross to ro-tau-LacZ reported did not show mistrageting or R2-R6 into the medulla thus 
Loco may act in a different pathway in the normal rap background (Fig. 8C).  
 
To study a possible interaction of rap/fzr with the locoP452 allele, a double mutant crosses 
were performed and third instar larvae were dissected and stained for the R cells in the eye 
imaginal disc. Surprisingly, loco which was previously shown to dominantly suppress rough eye 
phenotype in the adult Drosophila eye in genetic modifier screen (Kaplow, Mannava et al. 
2007), enhanced the axon bundling and mistargeting of the R axons in the lamina, medulla and 
lamina plexus in the third instar larvae. The lamina plexus shows an increased number of gaps 





Fig 13. Phenotypes of the rap mutants crossed to LocoP452. The rap phenotype is enhanced by 
the single copy of LocoP452. Axons show an increased bundling, more lamina plexus gaps and 
overall abnormal morphology of axonal projections. Shown axon projection patterns, stained 
with 24B10 in green. Arrows point the gaps in lamina plexus.  
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Double mutant rap/loco phenotype showed abnormal axon morphologies; thus, we 
decided to investigate whether loco itself has axonal length abnormalities. We measured retinal 
axon lengths, as described above, in LocoP452 allele and the significance of the results varied 
across the rap alleles and has a wide range of P values. Interestingly, the LocoP452/Tb exhibited 
significant increase in the lengths of the R cells suggesting a possible misregulation. The 
standard deviation and standard error are plotted in the Graph 2 and summarized in Table 2-3 in 
the Appendix. Also, the P values and their significance are listed in Table 3. The axonal length in 
the LocoP452/Tb stock showed a significant increase in the axonal projections and the average 
lengths of the axonal projections, their significance and standard error are summarized in Table 4 
in the Appendix and Figure 14, (33.15%, P value=<0.0001, St. Dev.=5.855, n=8; 37.86%, P 
value=0.0385, St. Dev.=34.26, n=8; 40.83%, P value=0.0026, St. Dev.=53.24, n=8 for R1-R6 
cells, R7-8 cells, lamina plexus lengths, respectively). These results suggest that rap/fzr plays a 
role in the axonal development, targeting and length while loco helps to coordinate the axonal 
length. It also suggests that Loco and Rap may be involved in another pathway that allows for a 
cross-talk since double mutant Rap/Loco do not show the same phenotype but an enhancement 
of the rap phenotype.  
 


































Figure 14. Histogram representing LocoP452/Tb allele R cell photoreceptor measurements. The 
measurements shows the following 33.15%, P value=<0.0001, St. Dev.=5.855, n=8; 37.86%, P 
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value=0.0385, St. Dev.=34.26, n=8; 40.83%, P value=0.0026, St. Dev.=53.24, n=8 for R1-R6 
cells, R7-8 cells, lamina plexus lengths, respectively. 
 
C6. Rap/Fzr and Liprin-α interact in retinal axon targeting 
 
Liprin-α has been recently shown to be involved in photoreceptor axonal targeting (Choe, 
Prakash et al. 2006; Hofmeyer, Maurel-Zaffran et al. 2006); thus, it remains unknown whether 
Rap/Fzr and Liprin-α interact in retinal axon targeting. Liprin-α was shown to play a significant 
role in the neuromuscular junction where it acts as a scaffolding molecule that binds RNA and 
lipid membranes via SAM motifs (Kaufmann, DeProto et al. 2002). To investigate whether 
Rap/Fzr interacts with Liprin-α in axon targeting in the third instar larvae, double 
mutants were generated. Previous work has shown that Liprin-α is a substrate for APC/Cdh1 
and that it affects the axon target selection in R1-R6 photoreceptors (Choe, Prakash et al. 2006). 
Liprin-α mutants showed defective axon guidance and were shown to be required presynaptically 
to mediate adhesive events between pre- and postsynaptic cells (Choe, Prakash et al. 2006). 
Hofmeyer (2006) showed that Liprin-α overexpression can partially restore R7 targeting and its 
removal may worsen the targeting when LAR is absent.  
 
To study a possible interaction of rap/fzr with the Liprin-α alleles, a double mutant 
crosses were performed and third instar larvae were dissected and stained for the R cells in the 
eye imaginal disc. The data showed axonal clumping, disorganized lamina and medulla with 
gaps in the lamina plexus. The preliminary data suggests that Liprin-α enhances the rap partial-
loss-of function phenotype. Two Liprin-α stocks were mutated with a P-insertion in the open 
reading frame of Liprin- α located on 2L (27A1 ) for 8561 20478 stock and 22459. While stock 
8563 was generated by an imprecise excision of the P{lacW} element, removing the Liprin-α 
coding region. Some of the Liprin-α 5' UTR and some P-element sequences are still present 
(Kaufmann, DeProto et al. 2002).  
 
 The preliminary data shows an enhancement of the rap phenotype in the photoreceptor 
axon targeting. Axons appear clumped, with disorganized lamina plexus and gaps. The double 
mutant eye imaginal discs seem to add up their phenotypes and enhance the overall appearance 
(Fig 15 and Fig 16). Our results show that the partial loss-of-function rap phenotype is enhanced 
by a single copy of the mutant Liprin-α. This is consistent with a role for Rap/Fzr in the 
degradation of Liprin-α as previously suggested (Choe, Prakash et al. 2006). Thus, it is possible 
that Rap and Liprin-α may be involved in a cross-talk regulating axon targeting.  




Figure 15. Liprin-α and rap double mutant crosses show axon projection patterns. Stained with 24B10= GREEN. The rap phenotype 
is enhanced by a single copy of Liprin-α by causing additional number of gaps in the lamina plexus, increased axonal clumping, 
disorganized lamina plexus and medulla. Genotypes: A) +/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/+; +/+ ; B) rapE2/Y; 
P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/+; +/+ ; C) rapE4/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/+; +/+ ; 
D) rapE6/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/+; +/+; E) rapx-2/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-
alpha[DG23609]/+; +/+ ; F) rapx-3/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/+; +/+ ; G) w,rap3/Y; P{y[+t7.7] 
w[+mC]=wHy}Liprin-alpha[DG23609]/+; +/+ ; H) +/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/; +/+; I) rapE2/Y; 
P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/; +/+; J) rapE4/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/; 
+/+; K) rapE6/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/; +/+; K) rapx-2/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-





Figure 16. Liprin-α and rap double mutant crosses show axon projection patterns. Stained with 
24B10=GREEN. This image shows Liprin-α/Rap double mutant side-by-side single rap mutants. 
Genotypes: A) rapE2; B) rapE4; C) rapE6; D) rapx-3; E) rapE2/Y; Df(2L)Liprin-alpha[R60], 
Liprin-alpha[R60]/+; +/+ ; F) rapE4/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/+; +/+ ; G) 
rapE6/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/+; +/+ ; H) rapx-3/Y; Df(2L)Liprin-
alpha[R60], Liprin-alpha[R60]/+; +/+ 
 
C7. Rap/Fzr shows dominant interactions with Ras 
 
Loco and Ras were shown to interact in mammals. Loco acts as scaffolding protein for 
Ras. Thus, it is unknown whether Rap and Ras interact. Ras protein plays critical roles in the 
regulation of cell growth and differentiation and a myriad of cancers have mutated Ras genes. 
Ras-binding domain (RBD) of Raf is homologous to Loco; thus, there may be a “cross-talk” 
between the Ras and Rap/Loco pathways (Ponting 1999). Thus, to investigate possible 
interaction of rap with Ras in the development of Drosophila adult eye, rap/RasV12 double 
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mutants were generated, crossing 22 lines of RasV12 to all rap alleles. We asked whether Rap/Fzr 
show dominant interactions with Ras. rap loss-of-function allele mutants were crossed to RasV12, 
a constitutively active oncogene. Ras is a well studied oncogene that can be activated by single 
amino acid substitution (Tabin, Bradley et al. 1982). RasV12 is a glycine to valine mutation at 
residue 12 in the P-loop. This prevents GTPase domain to be inactivated by GAP and makes it 
constitutively active (Wu, Pastor-Pareja et al. 2010).  
 
Our results show an enhancement of the rough eye phenotype that is allele specific and 
gene dosage sensitive. Stronger rap loss-of-function alleles caused stronger effect with RasV12 on 
the phenotype. Many lines of RasV12 crossed to w,rap3, caused an increased female lethality. 
Rap alleles show an allele specific phenotype suggesting a dosage dependent phenotype. This 
means that the more severe the rap allele is the more effect it may have on the Ras/Rap 
interaction. In addition, females are homozygous for the rap allele while males are hemizygous 
what may play an effect since the rap females were used for the cross and may have an increased 
expression of the Rap protein and possible enhancement of the phenotype in the rap/Ras double 
mutants. 
  
 Dissecting the pupal lethal larvae showed abnormal eye morphology which most likely 
caused the lethality. Stronger allele such as rapx-2, rapx-3, and w, rap3caused additional 
abnormalities such as formation of holes in the adult eye, formation of black turmogenic tissue 
deposits of the epithelial tissue, and often caused a decrease in the overall eye size. The holes in 
the eyes were located vertically in the anterior-posterior direction. Interestingly, the wild type, 
CS, flies showed a similar to the double mutant phenotype thus it suggests that partial loss-of-
function of rap may provide a protection from the tumor formation when the heterozygous rap 
mutations are less severe and cause less severe rough eye. The stocks evaluated carried the same 
P insertion element with RasV12 and all of the stocks evaluated showed the above described 
trend with slight variations on the severity of the phenotype observed. It was surprising to see 
that the hemizygous rap double mutants were less severely affected than the heterozygous rap 
females. It suggests that although together with Rap, RasV12, functions are partially suppressed 
by the weak alleles of the loss-of-function rap. The data and the number of flies observed and 
analyzed are summarized in Tables 6-12. The adult eye phenotypes are shown below (Fig 17-23, 
26-34). Fig 26. shows heat shock induced expression of P{sevhs-Ras1N17} for comparison, that 
shown a slight reduction is the eye size but with no tumorgenic phenotype as shown in RasV12. 
Similarly, Fig 24. shows only slight enhancement, using Ras85D mutation, in the rough eye 









Table 5. Compares 
the adult eye 






 males females  
520 +++ +++ weak rough eye 
754 + + weak rough eye 
2526 + + weak rough eye 
5581 + + minimal change 
5582 - - weak rough eye 
5583 + +  
5584 + +  
5683 + +  
5689 - -  
5777 + +  
6561 + +  
6562 + +  
6563 + +  
6564 + +  
6565 + +  
6573 +++ +++ 
a lot of brown 
holes 
6574 ++ ++  
6575 + +  
6576 + +  
8340 - -  
16011 - -  
16839 - -  
 males females 
520 50+ 50+ 
754 50+ 50+ 
2526 50+ 50+ 
5581 50+ 50+ 
5582 50+ 50+ 
5583 50+ 50+ 
5584 50+ 50+ 
5683 50+ 50+ 
5689 50+ 50+ 
5777 50+ 50+ 
6561 50+ 50+ 
6562 50+ 50+ 
6563 50+ 50+ 
6564 50+ 50+ 
6565 50+ 50+ 
6573 50+ 50+ 
6574 50+ 50+ 
6575 50+ 50+ 
6576 50+ 50+ 
8340 50+ 50+ 
16011 50+ 50+ 









: Phenotype     
- no change    
+ rough eye    
++ black dots, rough eye   
+++ 
black dots, rough eye, brown 
holes   
++++ 
* 
black dots, rough eye, brown holes, black deposits on eye 















 520 ++ - ++ - 
754 ++ - ++ - 
2526 ++ - ++ - 
5581 ++ - ++ - 
5582 + - + - 
5583 +++ - +++ - 
5584 +++ - ++ - 
5683 ++ - ++ - 
5689 + - + - 
5777 ++ - ++ - 
6561 ++ - ++ - 
6562 ++ - ++ - 
6563 ++ - ++ - 
6564 ++ - ++ - 
6565 +++ - +++ - 
6573 +++ - +++ - 
6574 ++ - ++ - 
6575 +++ - ++ - 
6576 ++ - ++ - 
8340 - ---------- - --------- 
16011 - - - - 
16839 - - - - 










520 5 4 4 4 
754 28 25 50+ 50+ 
2526 18 24 33 25 
5581 21 26 28 25 
5582 13 18 17 16 
5583 17 16 10 30 
5584 11 16 12 22 
5683 18 27 30 33 
5689 31 35 50+ 43 
5777 21 - 30 - 
6561 43 40 50+ 50+ 
6562 17 25 13 17 
6563 24 38 22 50 
6564 34 34 26 32 
6565 11 15 24 24 
6573 50+ 50+ 48 50+ 
6574 27 23 34 42 
6575 24 40 24 31 
6576 50+ 28 30 46 
8340 - ---------- - --------- 
16011 - - - - 
16839 - - - - 

















520 ++ + ++ - 
754 ++ + ++ - 
2526 ++ + ++ - 
5581 ++ + ++ - 
5582 + + + - 
5583 ++ + ++ - 
5584 ++ + ++ - 
5683 ++ + ++ - 
5689 + + + - 
5777 ++ + ++ - 
6561 ++ + + - 
6562 ++ + ++ - 
6563 ++ + ++ - 
6564 ++ + ++ - 
6565 ++ + ++ - 
6573 ++ + ++ - 
6574 ++ + ++ - 
6575 ++ + ++ - 
6576 ++ + ++ - 
8340 + ----------- - ----------- 
16011 + + - - 
16839 + + - - 










520 24 24 25 30 
754 50+ 35 50+ 50+ 
2526 42 45 50+ 50+ 
5581 50+ 50+ 50+ 50+ 
5582 50+ 50+ 50+ 50+ 
5583 30 13 15 16 
5584 28 10 45 18 
5683 50+ 5 50+ 50+ 
5689 52 45 50+ 50+ 
5777 25 - 35 - 
6561 20 22 20 18 
6562 22 29 45 20 
6563 24 34 32 50+ 
6564 16 17 21 25 
6565 25 27 41 50+ 
6573 24 31 35 30 
6574 50+ 45 50+ 50+ 
6575 22 15 28 36 
6576 50+ 41 50+ 50+ 
8340 - ------------ - ------------ 
16011 - - - - 
16839 - - - - 














520 ++ + ++ - 
754 ++ + ++ - 
2526 ++ + ++ - 
5581 +++ + ++ - 
5582 + + ++ - 
5583 ++ + ++ - 
5584 ++ + ++ - 
5683 ++ + ++ - 
5689 + - + - 
5777 ++ + + - 
6561 ++ + ++ - 
6562 ++ + ++ - 
6563 ++ + ++ - 
6564 ++ + ++ - 
6565 +++ + ++ - 
6573 +++ + ++ - 
6574 ++ + ++ - 
6575 ++ + ++ - 
6576 + + ++ - 
8340 + ---------- - ---------- 
16011 + + - - 
16839 + + - - 










520 32 29 17 22 
754 50+ 50+ 50+ 50+ 
2526 39 40 50+ 50+ 
5581 7 8 7 7 
5582 50+ 40 50+ 50+ 
5583 50+ 36 41 11 
5584 3 0 2 3 
5683 50+ 50+ 50+ 50+ 
5689 31 27 50+ 42 
5777 0 - 2 - 
6561 13 50+ 50+ 40 
6562 31 25 38 32 
6563 28 20 28 45 
6564 20 14 19 24 
6565 17 13 15 20 
6573 21 23 19 27 
6574 25 40 25 50+ 
6575 41 50+ 50+ 50+ 
6576 22 26 40 24 
8340 - --------- - --------- 
16011 - - - - 
16839 - - - - 















520 ++ + +++ - 
754 ++++ + +++ - 
2526 +++ + +++ - 
5581 ++ + +++ - 
5582 ++ + ++ - 
5583 ++ + ++ - 
5584 +++ + +++ - 
5683 +++ + +++ - 
5689 ++ + ++ - 
5777 ++ ----------- ++ ----------- 
6561 ++ + ++ - 
6562 +++ + +++ - 
6563 ++ + +++ - 
6564 ++ + ++ - 
6565 +++ + +++ - 
6573 +++ + +++ - 
6574 +++ + +++ - 
6575 ++ + ++ - 
6576 +++ + +++ - 
8340 - ----------- - ----------- 
16011 + + - - 
16839 +  - - 










520 6 14 7 2 
754 13 8 27 23 
2526 18 40 30 30 
5581 30 42 50+ 50+ 
5582 25 50+ 50+ 50+ 
5583 9 7 12 10 
5584 12 4 9 1 
5683 16 21 33 17 
5689 10 5 15 18 
5777 17 - 23 - 
6561 17 18 10 18 
6562 50+ 50+ 50+ 50+ 
6563 50+ 47 31 50+ 
6564 21 17 32 25 
6565 29 27 23 21 
6573 21 30 30 26 
6574 13 23 27 37 
6575 35 31 40 42 
6576 16 23 33 42 
8340 - ---------- - -------- 
16011 - - - - 
16839 - - - - 















520 +++ + ++++ - 
754 +++ + ++++ - 
2526 +++ + ++++  
5581 +++ + ++++  
5582 ++ + + - 
5583 ++ + +++ - 
5584 +++ + ++++ - 
5683 +++ + +++ - 
5689 ++ + ++ - 
5777 ++ + ++ - 
6561 +++ + +++ - 
6562 ++ + +++ - 
6563 ++ + +++ - 
6564 ++ + +++ - 
6565 +++ + +++ - 
6573 +++ + ++++ - 
6574 +++ + +++ - 
6575 ++++ + ++++ - 
6576 +++ + +++ - 
8340 + ----------- - ---------- 
16011 + - - - 
16839 ++ + - - 










520 15 15 15 15 
754 50+ 9 12 25 
2526 50+ 45 50+ 50+ 
5581 45 28 14 47 
5582 50+ 20 50+ 30 
5583 50+ 50+ 50+ 50+ 
5584 45 14 26 15 
5683 50+ 42 50+ 50+ 
5689 21 10 50+ 40 
5777 16 - 19 - 
6561 12 13 22 25 
6562 15 20 13 27 
6563 6 18 10 50+ 
6564 27 48 44 50+ 
6565 32 29 26 50+ 
6573 25 25 8 27 
6574 35 41 29 44 
6575 15 11 14 10 
6576 14 22 43 50+ 
8340 - -------- - -------- 
16011 - - - - 
16839 - - - - 















520 +++ + lethal - 
754 ++ + lethal - 
2526 ++ + +++ - 
5581 ++ + ++++ - 
5582 ++ + + - 
5583 ++ + ++++ - 
5584 ++ + lethal - 
5683 ++ + ++++ - 
5689 ++ + ++ - 
5777 ++ + ++ - 
6561 +++ + +++ - 
6562 ++ + ++++ - 
6563 ++ + ++++ - 
6564 ++ + ++++ - 
6565 ++ + ++++ - 
6573 ++ + ++++ - 
6574 ++ + ++++ - 
6575 ++ + ++++ - 
6576 ++ + ++++ - 
8340 + --------- - --------- 
16011 + - - - 
16839 + - - - 










520 10 10 0 4 
754 25 32 0 33 
2526 35 30 1 40 
5581 50+ 50+ 8 50+ 
5582 27 25 40 35 
5583 20 12 22* 15 
5584 8 8 2 15 
5683 20 30 15 32 
5689 30 15 26 25 
5777 18 - 28 - 
6561 13 20 20 25 
6562 17 50+ 31 50+ 
6563 40 26 4 50+ 
6564 32 39 28* 32 
6565 28 24 4* 28 
6573 35 50+ 1* 50 
6574 25 19 21* 17 
6575 20 31 30* 50+ 
6576 15 31 15 26 
8340 - -------- - -------- 
16011 - - - - 
16839 - - - -  















520 ++++ - +++ - 
754 +++ - +++ - 
2526 +++ - +++ - 
5581 ++ - +++ - 
5582 + - + - 
5583 +++ - +++ - 
5584 ++++ - +++ - 
5683 +++ - +++ - 
5689 + - + - 
5777 ++ - ++ - 
6561 ++ - ++ - 
6562 +++ - +++ - 
6563 +++ - +++ - 
6564 ++ - +++ - 
6565 +++ - +++ - 
6573 +++ - +++ - 
6574 +++ - +++ - 
6575 +++ - +++ - 
6576 +++ - ++++ - 
8340 - ---------- ---------- ----------- 
16011 - - ---------- - 
16839 - - ---------- - 










520 20 24 17 25 
754 5 9 10 11 
2526 12 25 28 19 
5581 50+ 34 50+ 50+ 
5582 50+ 50+ 50+ 50+ 
5583 32 32 19 31 
5584 7 10 13 8 
5683 50+ 50+ 24 30 
5689 10 18 20 15 
5777 1 - 0 - 
6561 19 50+ 50+ 46 
6562 50+ 27 50+ 28 
6563 27 16 27 24 
6564 21 23 15 22 
6565 50+ 26 50+ 31 
6573 8 12 10 11 
6574 3 3 1 1 
6575 32 25 31 40 
6576 21 40 20 23 
8340 - - - - 
16011 - - - - 
16839 - - - - 





(520), Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1 
 
Figure 17. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (520) +/+; Df(2R)E3363/CyO, P{sevRas1.V12}FK1; +/+; A’) CS male, representative of the wild type; B) (520) +/Y; 
Df(2R)E3363/CyO, P{sevRas1.V12}FK1; +/+ ; C) Cs; D) Cs/+; CyO, P{sevRas1.V12}FK1/+; +/+ ; E) Cs/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; F) rapE2; G) rapE2/+; CyO, P{sevRas1.V12}FK1/+; +/+; H) rapE2/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; I) rapE4; J) rapE4/+; CyO, P{sevRas1.V12}FK1/+; +/+; K) rapE4/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; L) rapE6; M) rapE6/+; CyO, P{sevRas1.V12}FK1/+; +/+; N) rapE6/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; O) rapx-2; P) rapx-2/+; CyO, P{sevRas1.V12}FK1/+; +/+; Q) rapx-2/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; R) rapx-3; S) rapx-3/+; CyO, P{sevRas1.V12}FK1/+; +/+; T) rapx-3/Y; CyO, 





(754), Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1 
 
Figure 18. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (754)+/+; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; A’) CS male, representative of the wild type; B) (754)+/Y; 
Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; C) Cs; D) Cs/+; CyO, P{sevRas1.V12}FK1/+; +/+ ; E) Cs/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; F) rapE2; G) rapE2/+; CyO, P{sevRas1.V12}FK1/+; +/+; H) rapE2/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; I) rapE4; J) rapE4/+; CyO, P{sevRas1.V12}FK1/+; +/+; K) rapE4/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; L) rapE6; M) rapE6/+; CyO, P{sevRas1.V12}FK1/+; +/+; N) rapE6/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; O) rapx-2; P) rapx-2/+; CyO, P{sevRas1.V12}FK1/+; +/+; Q) rapx-2/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; R) rapx-3; S) rapx-3/+; CyO, P{sevRas1.V12}FK1/+; +/+; T) rapx-3/Y; CyO, 
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P{sevRas1.V12}FK1/+; +/+; U) w,rap3; W) w,rap3/+; CyO, P{sevRas1.V12}FK1/+; +/+; W) w,rap3/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+ 
 
(2526), w[1118]; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1 (5689), sev[14]; Ras85D[e1B]/TM3, Sb[1]  
 
Figure 19. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (2526) w1118/w1118; wdl1/CyO, P{sevRas1.V12}FK1/+; +/+; A’) CS male, representative of the wild type; B)(2526)w1118/Y; 
wdl1/CyO, P{ry[+t7.2]=sevRas1.V12}FK1/+; +/+; C) Cs; D) w1118/Cs; CyO, P{sevRas1.V12}FK1/+; +/+; E) Cs/Y; CyO, 
P{sevRas1.V12}FK1/+; +/+; F) rapE2; G) rapE2/+; CyO, P{sevRas1.V12}FK1/+; +/+; H) rapE2/Y; CyO, P{sevRas1.V12}FK1/+; 
+/+; I) rapE4; J) rapE4/+; CyO, P{sevRas1.V12}FK1/+; +/+; K) rapE4/Y; CyO, P{sevRas1.V12}FK1/+; +/+; L) rapE6; M) rapE6/+; 
CyO, P{sevRas1.V12}FK1/+; +/+; N) rapE6/Y; CyO, P{sevRas1.V12}FK1/+; +/+; O) rapx-2; P) rapx-2/+; CyO, 
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P{sevRas1.V12}FK1/+; +/+; Q) rapx-2/Y; CyO, P{sevRas1.V12}FK1/+; +/+; R) rapx-3; S) rapx-3/+; CyO, 
P{sevRas1.V12}FK1/+; +/+; T) rapx-3/Y; CyO, P{sevRas1.V12}FK1/+; +/+; U) w,rap3; V) w,rap3/+; CyO, 
P{sevRas1.V12}FK1/+; +/+; W) w,rap3/Y; CyO, P{sevRas1.V12}FK1/+; +/+ 
 
(5581), Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
-
 
Figure 20. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (5581) +/+; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(5581) +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) +/Cs; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; G) rapE2/+; +/+; 
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TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) rapE4; J) 
rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; L) 
rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) rapx-3/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; W) 
w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(5582), Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 

























(5583), Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 21. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (5583) +/+; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(5583) +/Y; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1], P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) +/Cs; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; G) 
rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) 
rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) 
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rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; W) w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(5584), Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 22. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (5584) +/+; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(5584) +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) +/Cs; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; G) 
rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) 
rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, 
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P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) 
rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; W) w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(5683), ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
-
 
Figure 23. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A )(5683) +/+; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) (5683) 
+/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) +/Cs; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; G) rapE2/+; +/+; 
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TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) rapE4; J) 
rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; L) 
rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) rapx-3/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; W) 
w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(5689) sev[14]; Ras85D[e1B]/TM3, Sb[1] 
 
Figure 24. Shows the adult eye phenotypes of the F1 from the double mutant rap and Ras85D crosses 
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A) (5689) +/+; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1]; A’) CS male, representative of the wild type; B) (5689) +/Y; +/+; sev[14]; 
Ras85D[e1B]/TM3, Sb[1]; C) Cs; D) w1118/Cs; sev[14]; Ras85D[e1B]/+; +/+; E) Cs/Y; sev[14]; Ras85D[e1B]/+; +/+; F) rapE2; G) 
rapE2/+; sev[14]; Ras85D[e1B]/+; +/+; H) rapE2/Y; sev[14]; Ras85D[e1B]/+; +/+; I) rapE4; J) rapE4/+; sev[14]; Ras85D[e1B]/+; 
+/+; K) rapE4/Y; sev[14]; Ras85D[e1B]/+; +/+; L) rapE6; M) rapE6/+; sev[14]; Ras85D[e1B]/+; +/+; N) rapE6/Y; sev[14]; 
Ras85D[e1B]/+; +/+; O) rapx-2; P) rapx-2/+; sev[14]; Ras85D[e1B]/+; +/+; Q) rapx-2/Y; sev[14]; Ras85D[e1B]/+; +/+; R) rapx-3; S) 
rapx-3/+; sev[14]; Ras85D[e1B]/+; +/+; T) rapx-3/Y; sev[14]; Ras85D[e1B]/+; +/+; U) w,rap3; V) w,rap3/+; sev[14]; 
Ras85D[e1B]/+; +/+; W) w,rap3/Y; sev[14]; Ras85D[e1B]/+; +/+ 
 




Figure 25. Shows the adult eye phenotypes of the F1 from the double mutant rap and hsRas crosses 
A) +/+; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1; A’) CS male, representative of the wild type; B) +/Y; +/+; P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1; C) rapE2; D) rapE2/+; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/+; E) rapE2/Y; +/+; P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1/+; F) rapE4; G) rapE4/+; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/+; H) rapE4/Y; +/+; P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1/+; I) rapx-2; J) rapx-2/+; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/+; K) rapx-2/Y; +/+; P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1/+; L) rapx-3; M) rapx-3/+; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/+; N) rapx-3/Y; +/+; P{w[+mW.hs]=sevhs-





(6561), SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 26. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (6561) +/+; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(6561) +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) +/Cs; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; G) 
rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) 
rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) 
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rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; W) w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(6562), Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 27. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A)(6562) +/+; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(6562) +/Y; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) 
+/Cs; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; 
G) rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) 
rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, 
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P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) 
rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; W) w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(6563), Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 28. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (6563) +/+; +/+ Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, 
representative of the wild type; B) (6563) +/+; +/+ Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) +/Cs; +/+; TM3, 
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P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; G) rapE2/+; +/+; 
TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) rapE4; J) 
rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; L) 
rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) rapx-3/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; W) 
w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 




Figure 29. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) +/+; +/+; SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) +/Y; +/+; 
SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) +/Cs; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; G) rapE2/+; +/+; 
TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) rapE4; J) 
rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; L) 
rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) rapx-3/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; W) 
w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 




Figure 30. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (6565) +/+; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; 
B) (6565) +/Y; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) 
Cs; D) +/Cs; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) 
RapE2; G) rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; I) rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) 
rapx-2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; T) rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, 




(6573), ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 31. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (6573) +/+; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(6573) +/Y; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) 
+/Cs; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; 
G) rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) 
rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) 
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rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; W) w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(6574), ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 32. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (6574) +/+; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(6574) +/Y; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) 
+/Cs; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; 
G) rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) 
rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
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Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) 
rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; W) w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(6575), ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 33. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
A) (6575) +/+; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(6575) +/Y; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) 
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+/Cs; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; 
G) rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) 
rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) 
rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; W) w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
 
(6576), ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
Figure 34. Shows the adult eye phenotypes of the F1 from the double mutant rap and RasV12 crosses 
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A) (6576) +/+; +/+; ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; A’) CS male, representative of the wild type; B) 
(6576) +/Y; +/+; ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]; C) Cs; D) 
+/Cs; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; E) Cs/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; F) RapE2; 
G) rapE2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; H) rapE2/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; I) 
rapE4; J) rapE4/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; K) rapE4/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; L) rapE6; M) rapE6/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; N) rapE6/Y; +/+; TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; O) rapx-2; P) rapx-2/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; Q) rapx-2/Y; 
+/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; R) rapx-3; S) rapx-3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; T) 
rapx-3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+; U) w,rap3; V) w,rap3/+; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1]/+; W) w,rap3/Y; +/+; TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1]/+ 
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C8. This study examined the mitotic disregulation level in the rap third instar eye discs. 
 
 It was previously shown that rap causes additional cell-cycle divisions in the brain lobes 
(Kaplow, Korayem et al. 2008). Also, the rap mutants show an abnormal phospho-histone3 
(Ser10) staining with cell division not restricted to the MF and differentiated regions of the eye 
disc. These results serve as a control for the future examination of the third instar eye imaginal 
disc in the double rap and RasV12 mutants to see if the RasV12 causes additional cell-cycle 
deregulation or suppresses the phenotype (Fig 35.). 
 
Figure 35. Shows rap allele phospho-histone 3 (Ser10) staining with deregulated mitotic cell 
division. Genotypes: A-D) Cs/Y; E-H) rapx-2/Y; I-L) rapx-3/Y; M-P) w,rap3/Y 
D. CONCLUSION  
The work presented in this thesis was conducted to test the hypothesis that Rap/Fzr, a 
Drosophila homolog of the mammalian Cdh1 is important for correct axon targeting. The results 
show that rap plays a role in axon length determination. rap alleles showed abnormal axonal 
projections with clumping or photoreceptor axons, causing abnormal lamina, lamina plexus, and 
medulla morphology. rap alleles showed allele specific variations in the abnormal phenotype 
suggesting that Rap operates in a gene dosage dependent manner. Measurements of the 
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photoreceptor axons confirmed overgrowth as previously shown in mammalian data (Konishi, 
Stegmuller et al. 2004). The results indicate that Rap/Fzr plays a role in the determination of 
axonal growth and inhibits axonal growth; thus, partial loss of function shows an increased 
length of the photoreceptor axons. The data utilizing ro-tau-lacZ reporter suggests that in rap 
partial loss-of-function alleles cause developmental axonal changes, possibly changing the 
photoreceptor outgrowth or affecting proper R cell axon targeting since some R2-R5 crossed the 
lamina plexus and terminated in the medulla, a normal target only for R7 and R8.  
 
Loss-of-function mosaic studies utilizing FLP/FRT system suggest that Rap/Fzr functions 
cell autonomously in retinal axon targeting. Our preliminary data show that the regions of the 
rap-/rap-clones show aberrant axon projections. Clumping of axons and various gaps in the 
lamina plexus were observed in the clone patches but the general morphology of the surrounding 
cells is normal. These data suggest that Rap/Fzr function is cell autonomous but additional 
experiments need to be performed for more definitive conclusions. One possible way would be 
to use MARCM, mosaic analysis with a repressible marker, that allows visualization of a single 
cell clone in the heterozygous wild type background (Lee and Luo 2001). 
 
 In addition gain-of-function experiments utilizing GAL4/UAS and FLP/FRT systems 
showed that Rap/Fzr modulates proper axon targeting and length. Gain-of-function of rap/fzr in 
the eye imaginal disc causes axonal clumping, disorganization of lamina plexus with many gaps. 
Lamina plexus shows clusters of R cells fluctuating from the proper orientation in a step-wise 
fashion. It suggests that the overexpression of Rap causes an increased number of neurons that 
cannot fit onto the plane of the lamina plexus and cause the disorganization of that region. 
Although, the photoreceptor axons were not measured the length of the R cells is significantly 
decreased. Further measurements are necessary to assess the significance and severity of the 
decrease. These data suggest that Rap/Fzr is necessary for proper axonal targeting and proper 
development of the Drosophila visual system.  
 
To test for additional Rap interactions we generated double mutants with Loco, Liprin-α, 
and Ras mutations. Previous studies have shown that Rap, an ubiquitin ligase, targets Loco for 
ubiquitination and degradation (Kaplow, Korayem et al. 2008), thus we decided to investigate 
possible interactions of Rap and Loco in axonal targeting asking whether Loco dominantly 
interact with rap to regulate axon targeting. Loco was previously shown to affect the number of 
neurons and glia (Kaplow, Korayem et al. 2008); thus, it may play a role in axonal targeting. 
Surprisingly, loco which was previously shown to dominantly suppress rough eye phenotype in 
the adult Drosophila eye in genetic modifier screen (Kaplow, Mannava et al. 2007), enhanced 
the axon bundling and mistargeting of the R axons in the lamina, medulla and lamina plexus in 
the third instar larvae. The lamina plexus shows an increased number of gaps and axon bundling 
than the single mutant rap alleles. Statistical analysis of Loco showed significant increase in the 
lengths of the R cells suggesting a possible misregulation. These results suggest that rap/fzr 
plays a role in the axonal development, targeting and length while loco helps to coordinate the 
axonal length. It also suggests that Loco and Rap may be involved in another pathway that 
allows for a cross-talk since double mutant Rap/Loco do not show the same phenotype but an 




In addition, Liprin-α has been recently shown to be involved in photoreceptor axonal 
targeting (Choe, Prakash et al. 2006; Hofmeyer, Maurel-Zaffran et al. 2006); thus, it remains 
unknown whether Rap/Fzr and Liprin-α interact in retinal axon targeting. To investigate whether 
Rap/Fzr interacts with Liprin-α in axon targeting in the third instar larvae, double mutants were 
generated. The data from rap/fzr/Liprin-α double mutant crosses showed axonal clumping, 
disorganized lamina and medulla with gaps in the lamina plexus. The preliminary data suggests 
that Liprin-α enhances the rap partial-loss-of function phenotype. Our results show that the 
partial loss-of-function rap phenotype is enhanced by a single copy of the mutant Liprin-α. This 
is consistent with a role for Rap/Fzr in the degradation of Liprin-α as previously suggested 
(Choe, Prakash et al. 2006). Thus, it is possible that Rap and Liprin-α may be involved in a 
cross-talk regulating axon targeting. 
 
Also, Loco and Ras were shown to interact in mammals. Loco acts as scaffolding protein 
for Ras. Thus, it is unknown whether Rap and Ras interact. Ras protein plays critical roles in the 
regulation of cell growth and differentiation and a myriad of cancers have mutated Ras genes. 
Ras-binding domain (RBD) of Raf is homologous to Loco; thus, there may be a “cross-talk” 
between the Ras and Rap/Loco pathways (Ponting 1999). Thus, to investigate possible 
interaction of rap with Ras in the development of Drosophila adult eye, rap/RasV12 double 
mutants were generated, crossing 22 lines of RasV12 to all rap alleles. We asked whether Rap/Fzr 
show dominant interactions with Ras. rap loss-of-function allele mutants were crossed to RasV12, 
a constitutively active oncogene. Ras is a well studied oncogene that can be activated by single 
amino acid substitution (Tabin, Bradley et al. 1982). RasV12 is a glycine to valine mutation at 
residue 12 in the P-loop. This prevents GTPase domain to be inactivated by GAP and makes it 
constitutively active (Wu, Pastor-Pareja et al. 2010).  
Our results show an enhancement of the rough eye phenotype that is allele specific and gene 
dosage sensitive. Stronger rap loss-of-function alleles caused stronger effect with RasV12 on the 
phenotype with some female pupa lethality. Rap alleles show an allele specific phenotype 
suggesting a dosage dependent phenotype. This means that the more severe the rap allele is the 
more effect it may have on the Ras/Rap interaction. The data suggest that although together with 
Rap, RasV12, functions are partially suppressed by the weak alleles of the loss-of-function rap. 
 
 Additional data is needed on the protein expression levels in rap and double mutants to 
check for the allele specific phenotypes. Also, identification of the mutations is rap is necessary 
to see whether the regulatory regions of rap are affected or whether it is a structural change in 
the Rap protein that causes the phenotype. In addition, future studies should investigate the 
axonal lengths of the double mutant crosses with rap and possible look for additional Rap 
targets. Axonal elongation may play a role in treating axonal regeneration thus additional 
experiments that would test the rap effect in the injury may shed a light on the axonal 
regeneration properties. The mammalian data has shown that Cdh1 mutants were able to extend 
axons in the presence of myelin, an inhibitor of axonal regeneration and lengthening.  
 
E. MATERIALS AND METHODS  
Fly stocks and culture 
 The stocks were maintained at 25°C on standard corn meal-agar medium.  
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Rap stocks used: rap mutants alleles were generated by (Pimentel and Venkatesh 2005) using 
EMS and X-ray mutagenesis: rapx-3, rapx-2, w,rap3, rapE2, rap E4, rapE6 
For R2-R6 axonal pattern we used ro-tau lacZ (gift from Iris Salecker).  
Overexpression studies were performed with the following stocks: Repo-Gal4/Tb, (733) UAS-fzr 
II.I. 
For mosaic analysis we used FRT19, Ubi-GFP, eyFLP1 (gift from Jessica Treisman), (111943) 
w67c23P{lacW}rapG0418P{neoFRT}19A/FM7c; P{ey-FLP.DN}5 (Kyoto Institute of Technology), 
hsp.FLP; Act>CD2>Gal4 UAS-GFP/TM6B.  
Stocks used for balancing: 
w; If/CyO; MKRS/Tb; w; Tm3,Sb/Tm6,Tb; yw; lwr3-4(2)/CyO-Act-GPF (gift from Shuba 
Govind)  
Bloomington Drosophila Stock Center Stock list 
 Ras stocks used:  
(520), Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1 
(754), Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1 
(2526), w[1118]; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1 (5689), sev[14]; 
Ras85D[e1B]/TM3, Sb[1] (5777), P{w[+mW.hs]=sevhs-Ras1[N17]}JA1  
(5581), Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(5582), Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(5583), Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(5584), Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(5683), ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(5689), sev[14]; Ras85D[e1B]/TM3, Sb[1] 
(6561), SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(6562), Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 




(6564), SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(6565), 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(6573), ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(6574), ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(6575), ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(6576), ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
(8340), P{w[+mC]=vgMQ-Ras85D.V12}1, y[1] w[1118] 
(16011), y[1] w[1118]; PBac{w[+mC]=5HPw[+]}Ras85D[A014]/TM3, Sb[1] Ser[1] 
(16839), y[1] w[67c23]; P{w[+mC] y[+mDint2]=EPgy2}Ras85D[EY07538]/TM3, Sb[1] Ser[1] 
Liprin stocks used: 
(8561), w[*]; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/CyO, P{w[+mC]=ActGFP}JMR1 
(8563), Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1] 
(20478), y[1] w[67c23]; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/SM6a 
(22459), y[1] w[67c23]; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO 
Loco-stocks used: 
Locop452/Tb; (10009), P{ry[+*]=lacZ-un1}loco[rC56]; (14421), y[1]; ry[506] P{y[+mDint2] 
w[BR.E.BR]=SUPor-P}loco[KG02176]/TM3, Sb[1] Ser[1]; (19915), y[1] w[67c23]; P{w[+mC] 
y[+mDint2]=EPgy2}loco[EY04589]; (25055), w[1118]; Df(3R)BSC527/TM6C, Sb[1]; (26883), 
w[*]; P{w[+mC]=EP}loco[GE24954] 
Rap allele Phenotype  Classification Mutagen 
rapx-3 Rough eye in males Partial loss of function x-rays 
rapx-2 Rough eye in males Partial loss of function x-rays 
w,rap3 Rough eye in males Partial loss of function p-element 
rapE2 Rough eye in males Partial loss of function EMS 
rapE4 Rough eye in males Partial loss of function EMS 
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rapE6 Rough eye in males Partial loss of function EMS 
 
The detailed schematics of the all the crosses used are listed in the Appendix at the end of 




 Third instar larval eye discs and brains were dissected in PBS and stained with the 
primary antibodies and counterstained with a secondary antibody. 4% paraformaldehyde solution 
was used to fix the tissues with pH of 7.4. Primary antibodies were incubated for 2 hours at room 
temperature or overnight at 4ºC. Primary antibodies used: Mab24B10 (Zipursky, Venkatesh, and 
Benzer, 1985) were used to visualize photoreceptor axons (1:5) supernatant obtained from 
Developmental Studies Hybridoma Bank; Mab24B10 specifically stains photoreceptor cells in 
the retina and their axonal projections to the optic ganglion (Zipursky, Venkatesh et al. 1985); , 
Anti-phospho-histone3 (Ser10); Phosphorylation on Ser 10 of histone H3 is a mitotic marker; 
anti-rabbit Mitosis Marker from Millipore (1:100); ELAV-9F8A9-S anti-mouse (1:5) from 
Developmental Studies Hybridoma Bank; anti-β-galactosidase polyclonal rabbit (1:500) from 
Bioscience, rabbit anti-GFP (1:500) polyclonal rabbit (1:500) from Chemicon; rabbit anti-Repo 
polyclonal (1:500). The tissues were washed in 1XPBS three times for 20 minutes and incubated 
in the secondary antibody for 90 minutes at room temperature. Secondary antibodies used: 
Fluorescein (FITC)-conjugated AffinityPure goat Anti-Mouse IgG (H+L) (1:100), Rhodamine 
(TRITC)-conjugated affinity pure goat anti-mouse (1:100), Rhodamine (TRITC)-conjugated 
affinity pure goat anti-rabbit (1:100), Cy5-conjugated affinity pure F(ab’)2 goat anti-rabbit 
(1:100), goat-anti rabbit FITC IgG (H+L) (1:100) Jackson-ImmunoResearch Laboratories. The 
tissues were washed three times with 1XPBT and mounted using Vectashield Mounting 
Medium, Vector Laboratories. The fluorescent samples were visualized using confocal 
microscope LSM 510 (Zeiss). LSM Image Browser was used to capture, filter and visualize z-
stacks of the preparations. All images were visualized at 40x magnification 0.7 to 1.5 zoom and 
z-stack projections planes were compiled using LSM Image Browser. Images were edited with 
Adobe Photoshop CS3 and CS5.  
 
Mosaic analysis  
 
A mosaic analysis was performed by heat shocking first instar larvae for 15 or 30 min at 
37°C water bath 24 or 48 hours after egg lying for gain of function experiments. Ras (5777) 
crosses to rap flies was performed by heat shocking second instar larvae 48-72 hours after egg 
lying at 37°C for 20 minutes. Then the immunohistochemistry experiments were performed as 
described above.  
 
Adult eye images were generated in the following way: flies were collected 3-7 days after 
eclosion and placed into eppendorf tubes and stored in 70% ethanol at 4˚C. The flies were placed 
on a glass slide and the adult head was visualized with Nikon Digitan DS F1 digital camera using 
Nikon SM1000 dissecting microscope. The images were captured using NIC-Elements F 3.0. 





Analyses were performed with Prism 5 software (GraphPad Software). All statistical 
tests, significance was set to p<0.05. The two-tailed unpaired Student’s t-test and column 



















































































































































G, APPENDIX  
rap alleles Cs rapE2 rapE4 rapE6 rapx-2 rapx-3 w,rap3 
Average 
(µm) 





















































































Table 1. rap allele R cell photoreceptor measurements 
Statistics: 
Column statistics using Prism; optic stalk length: 
Optic stalk  Cs rapE2 rapE4 rapE6 rapx-2 rapx-3 w,rap3 locoP452/Tb
Number of values 10 8 7 7 3 11 15 8 
Std. Deviation 9.174 5.259 3.471 4.934 2.844 9.869 8.390 5.855 
Std. Error 2.901 1.859 1.312 1.865 1.642 2.975 2.166 2.070 
1-6 R cells  
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Std. Deviation 18.29 23.24 17.19 4.934 10.96 9.869 18.57 5.855 
Std. Error 5.782 8.218 6.497 1.865 6.330 2.975 4.795 2.070 
7-8 R cells  
Std. Deviation 22.68 20.27 24.76 35.19 9.120 23.43 50.16 34.26 
Std. Error 7.173 7.165 9.359 13.30 5.265 7.066 12.95 12.11 
Lamina plexus  
Number of values 10 8 7 7 3 11 15 8 
Std. Deviation 36.85 21.47 24.76 58.01 13.23 40.27 55.78 53.24 
Std. Error 11.65 7.592 9.359 21.93 7.640 12.14 14.40 18.82 
Table 2. Shows the standard deviations and standard error for the measurements of the rap and 
loco axonal projections  
T test results for optic stalk using Prism 




P value 0.1983 0.4468 0.3870 0.3335 0.3454 0.9357 0.2441 
Significant No No No No No No No 
1-6 R cells  
P value 0.0032 0.4661 < 0.0001 0.2318 < 0.0001 0.9238 < 0.0001 
Significant Yes No Yes No Yes No Yes 
7-8 R cells  
P value 0.1542 0.0038 0.4322 0.4200 0.3061 0.0437 0.0385 





P value 0.0054 0.0010 0.2161 0.5180 0.2588 0.0734 0.0026 
Significant Yes Yes No No No No Yes 
Table 3. Shows the t-test results with P values and significance of the measurements for the rap 
and loco axonal projections  
Alleles Cs LocoP452/Tb 
Average (µm) 19.537 26.02 
Optic stalk length 
Range (µm) 12.58-43.42 18.38-34.91 
Average (µm) 81.351 108.32025 1-6 receptor length 
Range (µm) 55.674-112.758 84.194-183.274 
Average (µm) 80.051 110.365 7-8 receptor lengths 
Range (µm)  39.552-111.932 73.078-168.786 
Average (µm) 184.923 260.44 Length of the lamina plexus 
 Range (µm) 119.55-237.25 212.47-256.63 
Table 4. LocoP452/Tb allele R cell photoreceptor measurements 
Genetic Crosses made: 
1. rap alleles and ro-tau lacZ 
rapE2/rapE2; +/+; +/+ x w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
rap E4/rapE4; +/+; +/+ x w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
rap E6/rapE6; +/+; +/+ x w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
rap x-2/rapx-2; +/+; +/+ x w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
rap x-3/rapx-3; +/+; +/+ x w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
w,rap3/w,rap3; +/+; +/+ x w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
Cs/Cs; +/+; +/+ x w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
w1118 /w1118; +/+; +/+ x w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
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+/+; +/+; LocoP452/Tbx w/Y; Bl/CyO; ro-tau lacZ/ro-tau lacZ 
2. Gain of function rap 
+/+; UAS-fzrII.I/UAS-fzrII.I;+/+ x hs.FLP/Y; +/+; Act>CD2>GAL4 UAS-GFP/TM6b 
+/+; UAS-fzrII.I/UAS-fzrII.I;+/+ x +/Y; +/+; Repo-GAL4/Tb 
3. rap alleles and Locop452 
rapE2/rapE2; +/+; +/+ x +/+; +/+; LocoP452/Tb 
rap E4/rapE4; +/+; +/+ x +/+; +/+; LocoP452/Tb 
rap E6/rapE6; +/+; +/+ x +/+; +/+; LocoP452/Tb 
rap x-2/rapx-2; +/+; +/+ x +/+; +/+; LocoP452/Tb 
rap x-3/rapx-3; +/+; +/+ x +/+; +/+; LocoP452/Tb 
w,rap3/w,rap3; +/+; +/+ x +/+; +/+; LocoP452/Tb 
Cs/Cs; +/+; +/+ x +/+; +/+; LocoP452/Tb 
w1118 /w1118; +/+; +/+ x +/+; +/+; LocoP452/Tb 
+/+; +/+; LocoP452/Tb x +/+; +/+; LocoP452/Tb 
4. Loss of function rap alleles 
(111943) w[67c23] P{w[+mC]=lacW}rap[G0418] P{neoFRT}19A/FM7c; P{ey-FLP.D}5/ 
P{ey-FLP.D}5; +/+ x FRT19, Ubi-GFP, eyFLP1/Y; +/+; +/+ 
(111943) w[67c23] P{w[+mC]=lacW}rap[G0418] P{neoFRT}19A/FM7c; P{ey-FLP.D}5/ 
P{ey-FLP.D}5; +/+ x FRT19, UbiGFP/Y; +/+; hs.FLP/TM6B 
5. rap alleles crosses to Liprin-alpha alleles 
a) Crosses or rap alleles to 8561 
rapE2/rapE2; +/+; +/+ x w[*]/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/CyO, 
P{w[+mC]=ActGFP}JMR1; +/+ 




rap E6/rapE6; +/+; +/+ x w[*]/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/CyO, 
P{w[+mC]=ActGFP}JMR1; +/+ 
rap x-2/rapx-2; +/+; +/+ x w[*]/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/CyO, 
P{w[+mC]=ActGFP}JMR1; +/+ 
rap x-3/rapx-3; +/+; +/+ x w[*]/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/CyO, 
P{w[+mC]=ActGFP}JMR1; +/+ 
w,rap3/w,rap3; +/+; +/+ x w[*]/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/CyO, 
P{w[+mC]=ActGFP}JMR1; +/+ 
Cs/Cs; +/+; +/+ x w[*]/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/CyO, 
P{w[+mC]=ActGFP}JMR1; +/+ 
w1118 /w1118; +/+; +/+ x w[*]/Y; Df(2L)Liprin-alpha[R60], Liprin-alpha[R60]/CyO, 
P{w[+mC]=ActGFP}JMR1; +/+ 
b) Crosses or rap alleles to 8563 
rapE2/rapE2; +/+; +/+ x +/Y; Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1]; +/+ 
rap E4/rapE4; +/+; +/+ x +/Y; Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1]; +/+ 
rap E6/rapE6; +/+; +/+ x +/Y; Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1]; +/+ 
rap x-2/rapx-2; +/+; +/+ x +/Y; Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1]; +/+ 
rap x-3/rapx-3; +/+; +/+ x +/Y; Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1]; +/+ 
w,rap3/w,rap3; +/+; +/+ x +/Y; Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1]; +/+ 
Cs/Cs; +/+; +/+ x +/Y; Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1]; +/+ 
w1118 /w1118; +/+; +/+ x +/Y; Liprin-alpha[F3ex15]/In(2LR)Gla, wg[Gla-1] Bc[1]; +/+ 
c) Balancing 20478 stock for third instar marker 
yw/Y; lwr3-4(2)/CyO-Act-GFP; +/+ x (20478) y[1] w[67c23]/; P{y[+t7.7] w[+mC]=wHy}Liprin-
alpha[DG23609]/SM6a; +/+  
d) Cross with balanced third instar marker on 20478 stock 




rap E4/rapE4; +/+; +/+ x yw/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/CyO-Act-
GFP; +/+ 
rap E6/rapE6; +/+; +/+ x yw/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/CyO-Act-
GFP; +/+ 
rap x-2/rapx-2; +/+; +/+ x yw/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/CyO-Act-
GFP; +/+ 
rap x-3/rapx-3; +/+; +/+ x yw/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/CyO-Act-
GFP; +/+ 
w,rap3/w,rap3; +/+; +/+ x yw/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/CyO-Act-
GFP; +/+ 
Cs/Cs; +/+; +/+ x yw/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/CyO-Act-GFP; +/+ 
w1118 /w1118; +/+; +/+ x yw/Y; P{y[+t7.7] w[+mC]=wHy}Liprin-alpha[DG23609]/CyO-Act-
GFP; +/+ 
e) Balancing 22459 stock for third instar marker 
yw/Y; lwr3-4(2)/CyO-Act-GFP; +/+ x (22459) y[1] w[67c23]/y[1] w[67c23]; P{w[+mC] 
y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO; +/+ 
f) Cross with balanced third instar marker on 22459 stock 
rapE2/rapE2; +/+; +/+ x yw/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO-Act-
GFP; +/+  
rap E4/rapE4; +/+; +/+ x yw/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO-
Act-GFP; +/+  
rap E6/rapE6; +/+; +/+ x yw/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO-
Act-GFP; +/+  
rap x-2/rapx-2; +/+; +/+ x yw/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO-
Act-GFP; +/+  
rap x-3/rapx-3; +/+; +/+ x yw/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO-
Act-GFP; +/+  
w,rap3/w,rap3; +/+; +/+ x yw/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO-
Act-GFP; +/+  
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Cs/Cs; +/+; +/+ x yw/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO-Act-
GFP; +/+  
w1118 /w1118; +/+; +/+ x yw/Y; P{w[+mC] y[+mDint2]=EPgy2}Liprin-alpha[EY21217]/CyO-
Act-GFP; +/+  
6.rap alleles crosses to Ras alleles for adult eye phenotype 
a) Crosses or rap alleles to 520 
rapE2/rapE2; +/+; +/+ x +/Y; Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap E4/rapE4; +/+; +/+ x +/Y; Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap E6/rapE6; +/+; +/+ x +/Y; Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap x-2/rapx-2; +/+; +/+ x +/Y; Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap x-3/rapx-3; +/+; +/+ x +/Y; Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
w,rap3/w,rap3; +/+; +/+ x +/Y; Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
Cs/Cs; +/+; +/+ x +/Y; Df(2R)E3363/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
b) Crosses or rap alleles to 754 
rapE2/rapE2; +/+; +/+ x +/Y; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap E4/rapE4; +/+; +/+ x +/Y; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap E6/rapE6; +/+; +/+ x +/Y; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap x-2/rapx-2; +/+; +/+ x +/Y; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap x-3/rapx-3; +/+; +/+ x +/Y; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
w,rap3/w,rap3; +/+; +/+ x +/Y; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
Cs/Cs; +/+; +/+ x +/Y; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
c) Crosses or rap alleles to 2526 
rapE2/rapE2; +/+; +/+ x w[1118]/Y; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap E4/rapE4; +/+; +/+ x w[1118]/Y; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap E6/rapE6; +/+; +/+ x w[1118]/Y; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
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rap x-2/rapx-2; +/+; +/+ x w[1118]/Y; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
rap x-3/rapx-3; +/+; +/+ x w[1118]/Y; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
w,rap3/w,rap3; +/+; +/+ x w[1118]/Y; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
Cs/Cs; +/+; +/+ x w[1118]/Y; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
d)Crosses or rap alleles to 5581 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
e) Crosses or rap alleles to 5582 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; Df(3L)XS543/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
f) Crosses or rap alleles to 5583 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
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rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; Df(3L)XS572/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
g) Crosses or rap alleles to 5584 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
i) Crosses or rap alleles to 5683 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
j) Crosses or rap alleles to 5689 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1] 
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rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1] 
k) Crosses or rap alleles to 5777 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/ P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/ P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/ P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/ P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/ P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/ 
P{w[+mW.hs]=sevhs-Ras1[N17]}JA1 
Cs/Cs; +/+; +/+ x +/Y; +/+; P{w[+mW.hs]=sevhs-Ras1[N17]}JA1/ P{w[+mW.hs]=sevhs-
Ras1[N17]}JA1 
l) Crosses or rap alleles to 6561 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
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m) Crosses or rap alleles to 6562 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
n) Crosses or rap alleles to 6563 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
o) Crosses or rap alleles to 6564 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
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rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; SR3-8[S-131]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
p) Crosses or rap alleles to 6565 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; 14-3-3epsilon[S-696]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
q) Crosses or rap alleles to 6573 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
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r) Crosses or rap alleles to 6574 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
s) Crosses or rap alleles to 6575 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w,rap3/w,rap3; +/+; +/+ x +/Y; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
Cs/Cs; +/+; +/+ x +/Y; +/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
t) Crosses or rap alleles to 6576 
rapE2/rapE2; +/+; +/+ x +/Y; +/+; ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E4/rapE4; +/+; +/+ x +/Y; +/+; ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap E6/rapE6; +/+; +/+ x +/Y; +/+; ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-2/rapx-2; +/+; +/+ x +/Y; +/+; ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
rap x-3/rapx-3; +/+; +/+ x +/Y; +/+; ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 




Cs/Cs; +/+; +/+ x +/Y; +/+; ER3-5[XE-2335]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
u) Crosses or rap alleles to 8340 
rapE2/rapE2; +/+; +/+ x P{w[+mC]=vgMQ-Ras85D.V12}1, y[1] w[1118]/Y; +/+; +/+ 
rap E4/rapE4; +/+; +/+ x P{w[+mC]=vgMQ-Ras85D.V12}1, y[1] w[1118]/Y; +/+; +/+ 
rap E6/rapE6; +/+; +/+ x P{w[+mC]=vgMQ-Ras85D.V12}1, y[1] w[1118]/Y; +/+; +/+ 
rap x-2/rapx-2; +/+; +/+ x P{w[+mC]=vgMQ-Ras85D.V12}1, y[1] w[1118]/Y; +/+; +/+ 
rap x-3/rapx-3; +/+; +/+ x P{w[+mC]=vgMQ-Ras85D.V12}1, y[1] w[1118]/Y; +/+; +/+ 
w,rap3/w,rap3; +/+; +/+ x P{w[+mC]=vgMQ-Ras85D.V12}1, y[1] w[1118]/Y; +/+; +/+ 
Cs/Cs; +/+; +/+ x P{w[+mC]=vgMQ-Ras85D.V12}1, y[1] w[1118]/Y; +/+; +/+ 
v) Crosses or rap alleles to 16011 
rapE2/rapE2; +/+; +/+ x y[1] w[1118]/Y; +/+; PBac{w[+mC]=5HPw[+]}Ras85D[A014]/TM3, 
Sb[1] Ser[1] 
rap E4/rapE4; +/+; +/+ x y[1] w[1118]/Y; +/+; PBac{w[+mC]=5HPw[+]}Ras85D[A014]/TM3, 
Sb[1] Ser[1] 
rap E6/rapE6; +/+; +/+ x y[1] w[1118]/Y; +/+; PBac{w[+mC]=5HPw[+]}Ras85D[A014]/TM3, 
Sb[1] Ser[1] 
rap x-2/rapx-2; +/+; +/+ x y[1] w[1118]/Y; +/+; PBac{w[+mC]=5HPw[+]}Ras85D[A014]/TM3, 
Sb[1] Ser[1] 
rap x-3/rapx-3; +/+; +/+ x y[1] w[1118]/Y; +/+; PBac{w[+mC]=5HPw[+]}Ras85D[A014]/TM3, 
Sb[1] Ser[1] 
w,rap3/w,rap3; +/+; +/+ x y[1] w[1118]/Y; +/+; PBac{w[+mC]=5HPw[+]}Ras85D[A014]/TM3, 
Sb[1] Ser[1] 
Cs/Cs; +/+; +/+ x y[1] w[1118]/Y; +/+; PBac{w[+mC]=5HPw[+]}Ras85D[A014]/TM3, Sb[1] 
Ser[1] 
w) Crosses or rap alleles to 16839 
rapE2/rapE2; +/+; +/+ x y[1] w[67c23]/Y; +/+; P{w[+mC] 
y[+mDint2]=EPgy2}Ras85D[EY07538]/TM3, Sb[1] Ser[1] 
Page | 86  
 
rap E4/rapE4; +/+; +/+ x y[1] w[67c23]/Y; +/+; P{w[+mC] 
y[+mDint2]=EPgy2}Ras85D[EY07538]/TM3, Sb[1] Ser[1] 
rap E6/rapE6; +/+; +/+ x y[1] w[67c23]/Y; +/+; P{w[+mC] 
y[+mDint2]=EPgy2}Ras85D[EY07538]/TM3, Sb[1] Ser[1] 
rap x-2/rapx-2; +/+; +/+ x y[1] w[67c23]/Y; +/+; P{w[+mC] 
y[+mDint2]=EPgy2}Ras85D[EY07538]/TM3, Sb[1] Ser[1] 
rap x-3/rapx-3; +/+; +/+ x y[1] w[67c23]/Y; +/+; P{w[+mC] 
y[+mDint2]=EPgy2}Ras85D[EY07538]/TM3, Sb[1] Ser[1] 
w,rap3/w,rap3; +/+; +/+ x y[1] w[67c23]/Y; +/+; P{w[+mC] 
y[+mDint2]=EPgy2}Ras85D[EY07538]/TM3, Sb[1] Ser[1] 
Cs/Cs; +/+; +/+ x y[1] w[67c23]/Y; +/+; P{w[+mC] 
y[+mDint2]=EPgy2}Ras85D[EY07538]/TM3, Sb[1] Ser[1] 
7.rap alleles crosses to Loco alleles for adult eye phenotype 
a) Crosses or Ras alleles to LocoP452 
+/+; +/+; LocoP452/Tb x (754) +/Y; Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
+/+; +/+; LocoP452/Tb x (2526) w[1118]/Y; wdl[1]/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
+/+; +/+; LocoP452/Tb x (5581) +/Y; +/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
+/+; +/+; LocoP452/Tb x (5584) +/Y; +/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
+/+; +/+; LocoP452/Tb x (5683) +/Y; +/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
+/+; +/+; LocoP452/Tb x (5689) +/Y; +/+; sev[14]; Ras85D[e1B]/TM3, Sb[1] 
+/+; +/+; LocoP452/Tb x (6561) +/Y; +/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, 
Sb[1] 
b) Crosses or Ras alleles to 10009 
+/+; +/+; P{ry[+*]=lacZ-un1}loco[rC56]/P{ry[+*]=lacZ-un1}loco[rC56] x (5581) +/Y; +/+; 
Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
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+/+; +/+; P{ry[+*]=lacZ-un1}loco[rC56]/P{ry[+*]=lacZ-un1}loco[rC56] x (5584) +/Y; +/+; 
Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
+/+; +/+; P{ry[+*]=lacZ-un1}loco[rC56]/P{ry[+*]=lacZ-un1}loco[rC56] x (6561) +/Y; +/+; 
SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
+/+; +/+; P{ry[+*]=lacZ-un1}loco[rC56]/P{ry[+*]=lacZ-un1}loco[rC56] x (6574) +/Y; +/+; 
ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
c) Crosses or Ras alleles to 19915  
y[1] w[67c23]/ y[1] w[67c23]; +/+; P{w[+mC] y[+mDint2]=EPgy2}loco[EY04589]/P{w[+mC] 
y[+mDint2]=EPgy2}loco[EY04589] x (5683) +/Y; +/+; ksr[S-627]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
y[1] w[67c23]/ y[1] w[67c23]; +/+; P{w[+mC] y[+mDint2]=EPgy2}loco[EY04589]/P{w[+mC] 
y[+mDint2]=EPgy2}loco[EY04589] x (6563) +/Y; +/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-
7[XS-5R]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
y[1] w[67c23]/ y[1] w[67c23]; +/+; P{w[+mC] y[+mDint2]=EPgy2}loco[EY04589]/P{w[+mC] 
y[+mDint2]=EPgy2}loco[EY04589] x (6575) +/Y; +/+; ER3-4[XE-2178]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
y[1] w[67c23]/ y[1] w[67c23]; +/+; P{w[+mC] y[+mDint2]=EPgy2}loco[EY04589]/P{w[+mC] 
y[+mDint2]=EPgy2}loco[EY04589] x (6576) +/Y; +/+; ER3-5[XE-2335]/TM3, 
P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
c) Crosses or Ras alleles to 26883 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (754) +/Y; 
Df(2R)vg-C/CyO, P{ry[+t7.2]=sevRas1.V12}FK1; +/+ 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (5581) +/Y; 
+/+; Df(3L)XS2182/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (5584) +/Y; 
+/+; Df(3L)XS705/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (5683) +/Y; 
+/+; ksr[S-627]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (6561) +/Y; 
+/+; SR3-2[S-432]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
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w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (6562) +/Y; 
+/+; Su(Tpl)[S-192]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (6563) +/Y; 
+/+; Df(3L)XS-5R, AP-2[XS-5R] SR3-7[XS-5R]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (6573) +/Y; 
+/+; ER3-2[XE-2551]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (6574) +/Y; 
+/+; ER3-3[XE-571]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
w[*]/w[*]; +/+; P{w[+mC]=EP}loco[GE24954]/P{w[+mC]=EP}loco[GE24954] x (6575) +/Y; 
+/+; ER3-4[XE-2178]/TM3, P{ry[+t7.2]=sevRas1.V12}FK2, Sb[1] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
